Alzheimer disease, including avohilmo

G6_ALZHEIMER_INCLAVO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G30 1 out of 7 registries used, show all original rules.	8857
4. Check minimum number of events None	8857
5. Include endpoints G6_ALZHEIMER	16916
6. Filter based on genotype QC (FinnGen only)	16916

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	G6_ALZHEIMER_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_ALZHEIMER
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G30
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer disease, including avohilmo based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16916	8078	8838
Unadjusted period prevalence (%)	3.35	2.75	3.90
Median age at first event (years)	80.13	80.19	80.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11008: Matched controls
85644

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F03

ICD-10 Finland

Unspecified dementia

8.3

323.0

2004

2244

N06DA02

ATC

donepezil; oral

73.5

323.0

5145

1009

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

72.7

323.0

2419

330

G30.0

ICD-10 Finland

Alzheimer disease with early onset

+∞

323.0

878

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

107.2

323.0

4004

454

G30

ICD-10 Finland

Alzheimer disease

+∞

323.0

972

P70

ICPC

Dementia

28.0

323.0

1286

403

N06DA04

ATC

galantamine; oral

34.2

323.0

1458

381

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

317.1

323.0

471

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.1

323.0

1377

2316

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.5

323.0

1918

4854

N05AX08

ATC

risperidone; systemic

10.2

323.0

2661

2584

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

67.4

323.0

1023

130

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.7

323.0

2843

4205

G30.1

ICD-10 Finland

Alzheimer disease with late onset

+∞

323.0

6534

A28

ICPC

Limited function/disability NOS

3.1

323.0

3541

11254

SPAT1053

SPAT

Memory test

4.1

323.0

4460

12147

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

37.3

323.0

1274

299

G30.8

ICD-10 Finland

Other Alzheimer disease

+∞

323.0

1965

N05AH04

ATC

quetiapine; oral

4.3

323.0

2210

4717

N06DX01

ATC

memantine; oral

90.8

323.0

5980

1106

N06DA03

ATC

rivastigmine; oral, transdermal

40.0

323.0

2982

788

F0019, G301

ICD-10 Finland

+∞

323.0

444

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

34.9

323.0

568

133

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

+∞

323.0

3375

P20

ICPC

Memory disturbance

8.8

323.0

5215

7963

SPAT1216

SPAT

Assessment of functional ability

2.6

305.7

2906

10443

R41.3

ICD-10 Finland

Other amnesia

6.2

290.1

877

1185

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

47.7

289.7

385

F009, G309

ICD-10 Finland

2391.6

288.8

307

R53

ICD-10 Finland

Malaise and fatigue

2.4

279.3

3007

11465

F06.7

ICD-10 Finland

Mild cognitive disorder

5.7

266.4

858

1253

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

245.0

1393

3520

SPAT1234

SPAT

Support of social functional capacity

3.7

219.3

1106

2528

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

219.2

4001

18935

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

193.7

2452

9833

AA1AD

NOMESCO Finland

CT of head and brain

2.0

185.9

3414

15944

SPAT1254

SPAT

Administration of medicine

2.2

184.4

2211

8617

WYA20

NOMESCO Finland

Home visit

7.8

182.4

462

478

N05BA04

ATC

oxazepam; oral

2.0

172.2

2856

12744

TAB00

NOMESCO Finland

Lumbar puncture

5.0

170.4

612

1003

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

166.9

2687

11821

N06AX11

ATC

mirtazapine; oral

1.9

166.8

3254

15403

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

165.6

3949

20047

L28

ICPC

Limited function/disability (L)

2.0

162.5

2475

10629

R41.0

ICD-10 Finland

Disorientation, unspecified

4.0

162.4

738

1527

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

122.6

157.9

186

F05.1

ICD-10 Finland

Delirium superimposed on dementia

14.0

151.0

282

161

F0009, G300

ICD-10 Finland

+∞

145.7

154

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

145.1

2001

8195

N06AB10

ATC

escitalopram; oral

2.3

135.3

1459

5326

N02BE01

ATC

paracetamol; systemic, rectal

1.8

131.7

8823

59247

A04

ICPC

Weakness/tiredness general

2.1

129.3

1695

6755

N03AG01

ATC

valproic acid; systemic, rectal

3.5

124.1

653

1522

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

123.9

891

2591

F0029, G308

ICD-10 Finland

+∞

111.6

118

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

106.5

793

2348

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.7

104.2

326

452

N05AH03

ATC

olanzapine; systemic

3.7

99.8

489

1073

N06AX26

ATC

vortioxetine; oral

3.9

99.4

449

918

SPAT1301

SPAT

No procedures

1.6

99.0

3643

20180

130

Kela drug reimbursment

Malignant tumour

0.3

98.5

244

5849

F0014, G301

ICD-10 Finland

+∞

95.5

101

AXX01

SPAT

5.3

94.5

315

472

A06AD11

ATC

lactulose; oral

1.7

93.2

2259

11101

F001, G301

ICD-10 Finland

108.0

92.5

110

SPAT1101

SPAT

Orthostatic test

2.5

92.5

809

2624

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

65.2

92.0

116

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.7

91.5

338

568

R55

ICD-10 Finland

Syncope and collapse

1.9

89.4

1562

6879

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

88.6

1771

8167

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

86.5

396

819

U04

ICPC

Incontinence urine

2.6

85.6

713

2247

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

83.5

721

2318

F00

ICD-10 Finland

Dementia in Alzheimer disease

18.9

82.7

137

Z75.5

ICD-10 Finland

Holiday relief care

5.3

82.3

273

407

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

82.0

1484

6601

S01.0

ICD-10 Finland

Open wound of scalp

2.2

81.6

948

3534

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

80.0

730

2417

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

78.6

1234

5208

A29

ICPC

General symptom/complaint other

1.9

77.3

1336

5837

I95.1

ICD-10 Finland

Orthostatic hypotension

2.5

76.5

646

2050

N05AD01

ATC

haloperidol; systemic

2.9

76.5

526

1476

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

76.5

1171

4891

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

117.6

76.4

G04CA02

ATC

tamsulosin; oral

1.5

75.7

3857

22679

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

7.4

74.5

193

207

SPAT1360

SPAT

Extensive global examination

2.1

73.4

979

3866

SPAT1252

SPAT

Overall medication plan or its review

2.0

73.4

1005

4011

SPAT1229

SPAT

Assessment of need for aid

1.9

71.9

1151

4881

H02AB02

ATC

dexamethasone; systemic

0.4

70.8

253

5179

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.9

70.6

470

1289

F21

ICPC

6.1

70.3

209

272

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

68.9

1741

19678

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.8

68.4

319

670

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

39.6

66.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

65.7

1639

8024

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

62.3

727

2704

R42

ICD-10 Finland

Dizziness and giddiness

1.5

61.7

2538

14092

N06AB04

ATC

citalopram; systemic

1.6

60.5

1944

10167

S06.0

ICD-10 Finland

Concussion

1.9

60.0

980

4174

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

58.6

654

2381

F05.9

ICD-10 Finland

Delirium, unspecified

3.0

57.1

358

945

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

56.9

3512

21133

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

56.2

1228

5758

SPAT1172

SPAT

Guidance concerning hydration

2.8

54.8

396

1145

S70.0

ICD-10 Finland

Contusion of hip

2.4

53.9

491

1618

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.2

53.7

224

426

C10AA01

ATC

simvastatin; oral

1.4

53.3

5713

37738

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

53.2

2066

11261

SPAT1050

SPAT

Extensive neurological examination

3.1

52.6

320

826

N02AA05

ATC

oxycodone; systemic

1.5

51.5

1834

9790

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

50.5

1953

10621

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

5.2

49.5

167

255

W19

ICD-10 Finland

Unspecified fall

1.8

47.3

978

4493

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

46.0

385

1212

SPAT1139

SPAT

Nutrition survey

2.5

46.0

391

1242

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

45.7

1040

4919

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

45.3

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

44.9

981

11587

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.8

44.6

790

3447

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

6.7

44.4

122

144

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

44.2

839

3747

F0011, G301

ICD-10 Finland

+∞

43.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

43.2

1369

7076

J01DB01

ATC

cefalexin; oral

1.3

42.8

7338

51255

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

41.8

665

2793

SPAT1251

SPAT

Organisation of medication

2.2

41.8

483

1785

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.7

41.7

309

907

E86

ICD-10 Finland

Volume depletion

2.5

41.7

366

1182

A04AA02

ATC

granisetron; systemic, transdermal

0.3

41.7

102

2478

N07AA05

ATC

350.1

40.9

N27

ICPC

Fear of neurological disease other

3.4

40.4

211

489

N05AD03

ATC

melperone; systemic

3.1

40.1

234

589

Z29

ICPC

Social problem NOS

3.3

39.9

215

510

R33

ICD-10 Finland

Retention of urine

1.6

39.8

1267

6548

A27

ICPC

Fear of other disease NOS

2.1

39.0

473

1783

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

37.1

3122

19472

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

37.0

2996

18570

SPAT1167

SPAT

Insertion of urinary catheter

2.0

36.9

505

2002

F0024, G308

ICD-10 Finland

+∞

36.8

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

36.7

1780

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

36.7

542

2214

N06AB06

ATC

sertraline; oral

1.8

36.7

635

2746

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

35.5

36.2

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

36.0

1775

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

35.6

1723

17658

F002, G308

ICD-10 Finland

83.9

35.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.4

35.0

317

1042

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

34.4

537

2240

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

34.3

445

1726

AA1AD

SPAT

13.7

34.2

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

33.5

890

4381

G31.0

ICD-10 Finland

Circumscribed brain atrophy

5.9

33.1

132

F01.2

ICD-10 Finland

Subcortical vascular dementia

5.1

32.5

109

167

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

32.5

588

2581

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.5

32.1

269

849

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.9

32.0

481

1977

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

31.9

505

2114

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

31.9

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

31.0

1688

9736

N30.0

ICD-10 Finland

Acute cystitis

1.5

30.1

1232

6714

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

29.8

1230

WX402

NOMESCO Finland

General anaesthesia

0.6

29.7

486

6161

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

6.0

29.2

113

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

29.0

1306

7257

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

28.5

697

3352

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

56.2

28.4

SPAT1263

SPAT

Sampling

1.3

28.3

3841

25362

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

28.2

927

4807

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

28.2

235

739

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

27.7

3818

25245

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

27.5

803

4047

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

27.5

326

1219

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

27.4

296

1063

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

27.3

685

3316

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

27.0

198

580

SPAT1153

SPAT

Removal of sutures

0.8

26.0

2168

20739

G04BD08

ATC

solifenacin; oral

1.6

25.9

778

3948

N28

ICPC

Limited function/disability (N)

2.6

25.2

197

600

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

24.6

314

1213

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

24.5

1493

8750

SPAT1236

SPAT

Informing family of child’s disability

2.4

24.5

224

744

A10AE04

ATC

insulin glargine; parenteral

1.5

24.2

882

4678

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

24.1

281

1042

S01BC05

ATC

ketorolac; ophthalmic

1.7

24.0

565

2686

SPAT1284

SPAT

Extensive health certificate

2.3

23.9

236

813

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

23.9

1444

14439

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

109.1

23.9

Z51.88

ICD-10 Finland

Other specified medical care

2.4

23.6

217

722

N17

ICPC

Vertigo/dizziness

1.4

23.5

1100

6144

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

23.4

1457

8567

Z28

ICPC

Limited function/disability (Z)

4.5

23.3

148

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

23.3

973

5311

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

23.2

824

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

22.9

2328

21812

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

72.8

22.9

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

17.4

22.9

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.2

22.8

253

919

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

22.7

3283

21694

A01

ICPC

Pain general/multiple sites

1.6

22.6

668

3373

A04AA01

ATC

ondansetron; systemic, rectal

0.5

22.6

184

2816

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

22.5

1146

6500

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

22.5

899

N29

ICPC

Neurological sympt/complt other

2.4

22.3

200

657

L01BC06

ATC

capecitabine; oral

0.4

22.1

1537

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

22.1

173

530

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.8

21.8

148

415

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

21.5

665

3395

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

21.5

1198

6904

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

37.7

21.5

WZC30

NOMESCO Finland

Teaching

0.7

21.4

550

6342

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

21.2

653

7282

P05

ICPC

Senility, feeling/behaving old

3.9

21.2

186

-2

ICPC

3.6

20.8

212

F0012, G301

ICD-10 Finland

+∞

20.8

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

20.5

235

869

J01EA01

ATC

trimethoprim; systemic

1.3

20.4

2271

14503

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

20.2

3261

21750

G04CB02

ATC

dutasteride; oral

1.4

20.0

944

5274

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.7

20.0

752

8102

XF606

SPAT

7.5

19.9

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

10.8

19.9

F0021, G308

ICD-10 Finland

+∞

19.8

F0013, G301

ICD-10 Finland

+∞

19.8

SPAT1262

SPAT

Handing over of treatment supplies

1.3

19.7

1789

11113

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

19.7

804

8549

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.2

19.7

209

747

J01MA02

ATC

ciprofloxacin; systemic

1.2

19.6

3880

26421

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

19.6

1303

12904

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

25.1

19.6

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

171.4

19.4

R11

ICD-10 Finland

Nausea and vomiting

1.5

19.4

669

3501

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

19.3

468

5465

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

19.0

423

1983

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

18.9

1063

6132

F0022, G308

ICD-10 Finland

+∞

18.9

F0004, G300

ICD-10 Finland

+∞

18.9

N07AA06

ATC

+∞

18.9

E000001

ATC

1.3

18.8

1602

9858

JN4AD

NOMESCO Finland

Body CT examination

0.6

18.8

337

4190

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

18.7

282

1162

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

18.6

1581

F22.0

ICD-10 Finland

Delusional disorder

2.7

18.5

132

382

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.5

18.5

153

485

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

18.3

4395

30441

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

18.3

486

2389

E0000UV

ATC

1.2

18.1

3135

21008

G04CA01

ATC

alfuzosin; oral

1.3

18.1

1432

8715

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

18.0

1577

F0023, G308

ICD-10 Finland

+∞

17.9

K59.0

ICD-10 Finland

Constipation

1.5

17.7

599

3122

S28

ICPC

Limited function/disability (S)

3.8

17.7

157

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

155.8

17.6

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.1

17.6

199

734

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

17.6

442

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

17.4

198

732

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

17.4

207

780

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.6

17.3

473

2343

SPAT1285

SPAT

Provision of consultation response

1.6

17.2

486

2428

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

17.2

475

2361

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

0.8

17.1

1776

16697

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

17.1

959

5523

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

17.1

443

5106

F0024, G301

ICD-10 Finland

+∞

17.0

F009, G301

ICD-10 Finland

+∞

17.0

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

17.0

803

8355

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

16.8

284

1221

115

Kela drug reimbursment

Breast cancer

0.6

16.8

230

3051

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

16.8

138

2107

SPAT1014

SPAT

Treatment of eyes

2.1

16.6

192

714

N06AX21

ATC

duloxetine; oral

1.5

16.5

604

3204

C03CA01

ATC

furosemide; systemic

1.2

16.4

4192

29109

LAITO

NOMESCO Finland

15.6

16.4

P29

ICPC

Psychological sympt/compl other

2.0

16.4

208

804

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

3.9

16.4

141

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.2

16.3

178

646

M01AH05

ATC

etoricoxib; oral

0.8

16.2

3140

27776

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

16.1

474

2392

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

16.1

1181

7102

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

16.0

132

2008

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

15.9

1466

9100

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.1

15.9

122

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.2

15.9

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.2

15.8

172

625

KMAK

NOMESCO Finland

1.2

15.6

3243

22057

G04BD12

ATC

mirabegron; oral

1.3

15.6

1076

6410

N06AX16

ATC

venlafaxine; oral

1.5

15.5

607

3265

RD211

NOMESCO Finland

0.5

15.5

1636

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.7

15.4

584

6294

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

15.3

628

3412

Z60.8

ICD-10 Finland

Other problems related to social environment

5.1

15.3

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

15.2

218

2854

N18

ICPC

Paralysis/weakness

2.0

15.0

202

800

R1250

SPAT

3.9

15.0

129

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

8.9

15.0

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

4.5

14.8

L03AA13

ATC

pegfilgrastim; parenteral

0.4

14.8

1237

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

14.8

1204

7349

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

6.6

14.8

D12

ICPC

Constipation

1.6

14.7

351

1679

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

6.2

14.7

HMAK

NOMESCO Finland

0.7

14.7

347

4075

U28

ICPC

Limited function/disability (U)

2.3

14.7

134

449

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.8

14.7

132

Y94.0

ICD-10 Finland

Accident at home

2.1

14.7

178

679

AA1CG

SPAT

4.3

14.6

WF002

NOMESCO Finland

Radical radiotherapy

0.6

14.5

195

2597

Z51.0

ICD-10 Finland

Radiotherapy session

0.2

14.5

540

K08.3

ICD-10 Finland

Retained dental root

1.5

14.4

550

2943

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.5

14.3

118

376

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

14.2

227

959

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

14.2

829

F000, G300

ICD-10 Finland

+∞

14.2

H02AB06

ATC

prednisolone; systemic

0.8

14.1

3581

31065

N02AX02

ATC

tramadol; systemic, rectal

0.8

14.1

3155

27658

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.0

14.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

14.1

215

894

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.7

14.1

133

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

14.0

1165

SPAT1058

SPAT

PEF monitoring instruction

0.7

14.0

340

3971

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

13.9

1480

13915

S01

ICD-10 Finland

Open wound of head

2.4

13.9

120

390

T05

ICPC

Feeding problem of adult

3.8

13.9

127

C04AE01

ATC

ergoloid mesylates; systemic

2.5

13.8

108

334

S01.8

ICD-10 Finland

Open wound of other parts of head

2.4

13.8

119

386

P04

ICPC

Feeling/behaving irritable/angry

6.7

13.8

Y94.1

ICD-10 Finland

Accident in connection with service housing

8.3

13.7

T08

ICPC

Weight loss

2.2

13.6

140

497

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

13.5

204

846

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

13.5

1434

9056

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

13.5

2081

18856

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

13.5

1080

A10BB12

ATC

glimepiride; oral

1.3

13.5

932

5552

XF606

NOMESCO Finland

Ortostatic test

2.7

13.4

273

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

13.4

237

1040

-1

ICPC

2.0

13.3

170

662

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.5

13.3

121

1790

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

13.3

511

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

13.3

174

2328

SPAT1125

SPAT

Stoma care and guidance

1.9

13.2

192

786

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

13.2

1279

F0019, G309

ICD-10 Finland

+∞

13.2

A23

ICPC

Risk factor NOS

1.6

13.2

324

1564

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

13.2

1015

9902

HA1AA

NOMESCO Finland

X-ray mammography

0.6

13.1

210

2679

P28

ICPC

Limited function/disability (P)

3.8

13.1

118

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

13.1

1384

W06

ICD-10 Finland

Fall involving bed

2.5

13.0

100

307

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

24.7

13.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

12.9

1071

N05AB03

ATC

perphenazine; systemic, rectal

1.8

12.8

218

944

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.9

12.8

105

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

12.8

1394

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.3

12.8

644

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

12.8

331

1621

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

19.5

12.8

N99

ICPC

Neurological disease other

2.4

12.8

108

350

SPAT1260

SPAT

Consultation of another employee

1.2

12.7

1533

9820

A98

ICPC

Health maint/preventive medicine

1.2

12.7

8163

60616

H02AA02

ATC

fludrocortisone; oral

2.4

12.7

110

360

R31

ICD-10 Finland

Unspecified haematuria

1.3

12.5

1234

7716

N03AX14

ATC

levetiracetam; systemic

1.9

12.4

191

798

A10AE05

ATC

insulin detemir; parenteral

1.5

12.3

435

2294

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

12.3

266

3176

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

12.3

925

5578

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

12.3

1255

7883

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

14.9

12.3

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.4

12.2

1061

L15

ICPC

Knee symptom/complaint

0.8

12.2

1124

10748

R03AC02

ATC

salbutamol; inhalant

0.9

12.2

3394

29327

UKC02

NOMESCO Finland

Cystoscopy

1.2

12.1

2005

13289

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.5

12.1

131

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.6

12.1

123

L02BG04

ATC

letrozole; oral

0.6

12.1

150

2033

SPAT1281

SPAT

Other administrative function

1.4

12.0

616

3491

G04BD07

ATC

tolterodine; oral

1.4

12.0

544

3017

R50.9

ICD-10 Finland

Fever, unspecified

1.3

12.0

1166

7279

L03AA02

ATC

filgrastim; parenteral

0.4

12.0

1029

C01DA14

ATC

isosorbide mononitrate; oral

1.2

12.0

2434

16448

JN4BD

NOMESCO Finland

Extensive body CT

0.7

11.9

656

6690

WW500

NOMESCO Finland

Blood transfusion

0.6

11.9

142

1944

S22.3

ICD-10 Finland

Fracture of rib

1.4

11.9

551

3068

L75

ICPC

Fracture: femur

2.1

11.8

143

545

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

0.6

11.8

199

2509

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

11.8

136

508

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.8

590

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

11.8

656

3772

A12AA04

ATC

calcium carbonate; oral

0.3

11.8

710

S18

ICPC

Laceration/cut

0.9

11.7

3147

27292

A78

ICPC

Infectious disease other/NOS

2.6

11.7

254

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

11.7

241

1110

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

11.7

1479

F05.8

ICD-10 Finland

Other delirium

2.6

11.6

269

SPAT1127

SPAT

Enema

2.3

11.6

109

373

R2110

NOMESCO Finland

Giving the first information

1.5

11.6

410

2161

F009, F03

ICD-10 Finland

10.5

11.6

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.1

11.6

139

530

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

11.5

298

1462

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

4.2

11.4

R06.0

ICD-10 Finland

Dyspnoea

0.8

11.4

1892

17078

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.6

11.4

299

1468

K91

ICPC

Cerebrovascular disease

2.0

11.4

153

609

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.5

11.4

104

1533

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.4

2224

14963

SPAT1244

SPAT

Occupational therapy

2.3

11.3

101

338

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

11.3

690

6936

U13

ICPC

Bladder symptom/complaint other

1.7

11.2

255

1206

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

11.2

189

2380

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

11.2

141

549

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

17.5

11.2

F00, F03

ICD-10 Finland

7.3

11.1

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

11.1

429

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.6

11.0

159

2072

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

10.9

308

3495

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

10.9

150

1981

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

10.9

1385

8920

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.6

10.9

159

2070

SPAT1138

SPAT

Guidance concerning bowel function

2.0

10.9

140

549

R35

ICD-10 Finland

Polyuria

1.4

10.8

623

3607

J01CA08

ATC

pivmecillinam; oral

1.2

10.7

2547

17424

C10AA02

ATC

lovastatin; oral

1.4

10.7

540

3054

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

10.6

155

639

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.5

10.6

264

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.6

10.5

101

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

10.5

1396

9037

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

10.5

159

2050

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.4

10.4

118

A11CC03

ATC

alfacalcidol; systemic

0.5

10.4

1077

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

10.4

ZXA00

NOMESCO Finland

Right side

1.2

10.3

2626

18053

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.2

10.3

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

10.3

592

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

10.3

437

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

10.3

279

S20.2

ICD-10 Finland

Contusion of thorax

1.5

10.3

353

1851

L08

ICPC

Shoulder symptom/complaint

0.8

10.3

1010

9597

P99

ICPC

Psychological disorders other

2.4

10.3

274

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

10.3

2067

13933

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

10.2

541

5543

D82

ICPC

Teeth/gum disease

0.8

10.2

1374

12648

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

10.2

372

1978

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

10.2

316

1622

Z03

ICPC

Housing/neighbourhood problem

2.9

10.2

159

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.9

10.2

141

571

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

10.1

519

ZX120

NOMESCO Finland

Intravenous

0.7

10.0

482

5011

SPAT1104

SPAT

Monitoring of emergency patient

1.4

10.0

574

3321

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.6

9.9

147

1906

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

9.9

1006

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

9.9

272

3099

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

4.7

9.9

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

9.9

380

2043

C09AA05

ATC

ramipril; oral

1.2

9.9

2802

19421

K90

ICPC

Stroke/cerebrovascular accident

1.5

9.9

308

1581

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

9.9

249

2881

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

9.8

739

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

9.8

1186

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.7

9.8

203

D07AA02

ATC

hydrocortisone; topical

1.3

9.8

903

5598

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.2

9.8

103

373

A04AA55

ATC

palonosetron, combinations; systemic

0.3

9.8

521

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

9.7

2499

17182

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.7

336

3674

Z43.5

ICD-10 Finland

Attention to cystostomy

2.4

9.5

266

G04BD10

ATC

darifenacin; oral

2.5

9.5

231

H91.1

ICD-10 Finland

Presbycusis

1.3

9.5

786

4803

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

9.5

751

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

9.5

965

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

9.4

1043

F0001, G300

ICD-10 Finland

+∞

9.4

F0021, G301

ICD-10 Finland

+∞

9.4

F0009, G309

ICD-10 Finland

+∞

9.4

HA1RA

SPAT

0.3

9.4

446

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.5

9.4

242

Z11

ICPC

Compliance/being ill problem

2.8

9.4

175

A69.2

ICD-10 Finland

Lyme disease

0.6

9.4

156

1966

Z51.5

ICD-10 Finland

Palliative care

1.3

9.3

641

3815

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

85.6

9.3

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

9.3

331

3600

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

9.3

289

1484

IHZ08

SPAT

16.7

9.3

H02AB07

ATC

prednisone; oral

0.8

9.3

907

8625

N05AH02

ATC

clozapine; systemic

3.1

9.2

126

TK800

NOMESCO Finland

Hemodialysis

0.4

9.2

821

R03DA04

ATC

theophylline; systemic, rectal

0.7

9.2

457

4725

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

9.1

161

708

R54

ICD-10 Finland

Senility

2.7

9.1

185

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

9.1

955

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

9.1

354

1911

G72.8

ICD-10 Finland

Other specified myopathies

1.8

9.1

151

652

XKD00

NOMESCO Finland

Uroflowmetry

1.2

9.1

2001

13581

EBA30

NOMESCO Finland

Excision of root of tooth

1.4

9.0

409

2273

SPAT1042

SPAT

Guidance concerning balance maintenance

2.5

9.0

210

A05

ICPC

Feeling ill

1.5

9.0

277

1423

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

1.6

9.0

221

1074

ZYC01

SPAT

1.5

9.0

272

1392

WW200

SPAT

1.4

8.9

497

2863

R44.1

ICD-10 Finland

Visual hallucinations

2.9

8.9

142

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

8.9

933

A99

ICPC

Disease/condition unspecnature/site

1.3

8.9

629

3760

G04BX04

ATC

1.5

8.9

265

1352

S42.0

ICD-10 Finland

Fracture of clavicle

1.7

8.8

176

805

R74

ICPC

Upper respiratory infection acute

0.8

8.8

813

7787

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.1

8.8

R40.2

ICD-10 Finland

Coma, unspecified

2.1

8.8

345

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

8.8

1050

9786

T82

ICPC

Obesity

0.4

8.7

606

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.7

8.7

182

846

XF600

SPAT

2.4

8.7

248

R45.5

ICD-10 Finland

Hostility

9.3

8.7

TGC00

NOMESCO Finland

Bronchial lavation

0.5

8.7

1132

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

8.7

115

459

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.7

8.7

173

793

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.7

786

4861

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

8.7

989

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.9

8.6

123

506

A04AD12

ATC

aprepitant; systemic

0.3

8.6

464

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

0.8

8.6

533

5347

C03DA01

ATC

spironolactone; oral

0.8

8.6

795

7606

J01FA10

ATC

azithromycin; systemic

0.9

8.6

2956

25318

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

8.5

380

2105

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.4

8.5

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.5

526

F009, G308

ICD-10 Finland

+∞

8.5

P19

ICPC

Drug abuse

4.4

8.4

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

8.4

966

9042

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

8.4

440

2507

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

8.4

431

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

8.4

487

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

8.4

430

2445

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

8.3

391

2188

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.3

8.3

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.6

8.3

141

1768

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.8

8.3

144

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.3

827

5180

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

8.2

192

920

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

8.2

243

2728

N81.1

ICD-10 Finland

Cystocele

0.7

8.2

230

2605

F06.0

ICD-10 Finland

Organic hallucinosis

4.3

8.2

A96

ICPC

Death

2.5

8.2

198

R4190

NOMESCO Finland

Nutritional therapy

0.4

8.2

728

L76

ICPC

Fracture: other

1.6

8.1

229

1153

I50.9

ICD-10 Finland

Heart failure, unspecified

1.2

8.1

1939

13232

M04AA01

ATC

allopurinol; systemic

0.8

8.1

1169

10707

B01AB10

ATC

tinzaparin; parenteral

0.7

8.1

312

3349

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

8.1

167

773

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

8.1

140

1748

S15

ICPC

Foreign body in skin

0.7

8.1

253

2810

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

8.1

122

513

L90

ICPC

Osteoarthrosis of knee

0.7

8.1

296

3202

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.8

8.1

990

9205

F32

ICD-10 Finland

Depressive episode

1.6

8.1

200

976

B01AA03

ATC

warfarin; systemic

1.1

8.1

2820

19801

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

8.0

408

R03BA08

ATC

ciclesonide; inhalant

0.7

8.0

261

2881

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.0

730

4518

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

8.0

3733

26702

N05CD07

ATC

temazepam; oral

1.2

8.0

1413

9391

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

8.0

180

855

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

3.1

8.0

115

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

8.0

606

5933

F01

ICD-10 Finland

Vascular dementia

2.7

8.0

156

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

2.2

8.0

301

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.8

8.0

133

579

G40

ICD-10 Finland

Epilepsy

2.6

8.0

176

LCA06

NOMESCO Finland

Biopsy of endometrium

0.7

8.0

249

2766

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

5.0

7.9

R45.1

ICD-10 Finland

Restlessness and agitation

4.4

7.9

N05AX12

ATC

aripiprazole; systemic

2.3

7.8

256

SPAT1243

SPAT

Psychiatric/psychological examination

2.3

7.8

232

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

7.8

851

5385

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

7.8

303

HAB99

NOMESCO Finland

Other partial excision of mammary gland

0.4

7.7

670

S82

ICPC

Naevus/mole

0.8

7.7

552

5440

P15

ICPC

Chronic alcohol abuse

2.0

7.7

372

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

7.7

140

1726

E87.6

ICD-10 Finland

Hypokalaemia

1.5

7.7

233

1194

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

5.3

7.7

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

7.4

7.7

A10BK03

ATC

empagliflozin; oral

0.7

7.7

235

2620

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

7.7

644

3944

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.7

2201

15230

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

7.6

462

N05CF01

ATC

zopiclone; oral

1.1

7.6

3198

22707

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

7.6

1346

12123

R01AD12

ATC

fluticasone furoate; nasal

0.8

7.6

984

9110

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

7.6

477

A10BH05

ATC

linagliptin; oral

1.3

7.6

498

2947

S06.3

ICD-10 Finland

Focal brain injury

1.8

7.6

120

512

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

7.6

472

2771

G03DC02

ATC

norethisterone; oral

0.7

7.5

306

3255

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.4

7.5

355

1989

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.2

7.5

809

5113

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

7.4

816

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

7.4

213

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

7.4

222

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.7

7.4

135

605

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.1

7.4

3751

26941

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.4

7.4

309

1693

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

7.4

358

3710

N05AA02

ATC

levomepromazine; systemic

1.5

7.4

269

1437

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.4

7.4

493

A10BJ06

ATC

semaglutide; parenteral

0.4

7.4

690

D07BC01

ATC

betamethasone and antiseptics; topical

1.2

7.3

912

5858

XA400

NOMESCO Finland

EEG

2.6

7.2

161

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

7.2

540

3258

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.3

7.2

570

3463

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

7.2

198

2250

XCH00

NOMESCO Finland

Eye pressure measurement

0.7

7.2

184

2118

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.2

7.2

263

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

3.0

7.2

107

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.1

7.2

310

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.2

7.2

N03AF02

ATC

oxcarbazepine; oral

1.6

7.2

200

1006

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.5

7.2

753

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

7.2

549

3322

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

7.1

1188

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

7.1

360

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.3

7.1

370

AXX01

NOMESCO Finland

Memory assessment

25.9

7.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

0.7

7.1

267

2876

Z08

ICPC

Social welfare problem

2.2

7.1

250

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

7.1

496

4898

L01CA04

ATC

vinorelbine; systemic

0.2

7.0

314

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.8

7.0

111

474

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.0

7.0

164

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

11.2

7.0

G04BE04

ATC

yohimbine; oral

1.8

7.0

124

552

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.8

7.0

426

4281

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

7.0

342

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.1

7.0

303

Z75.0

ICD-10 Finland

Medical services not available in home

3.3

6.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.1

6.9

3055

21734

C10AX09

ATC

ezetimibe; oral

0.8

6.9

607

5843

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

6.9

838

7805

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

6.9

1178

SPAT1111

SPAT

Planning of analgesia

2.0

6.8

350

T03

ICPC

Loss of appetite

3.3

6.8

M05BA02

ATC

clodronic acid; systemic

0.2

6.8

265

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

6.6

6.8

N95.0

ICD-10 Finland

Postmenopausal bleeding

0.7

6.8

300

3150

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.9

6.8

1402

12480

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.8

6.8

522

5099

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.8

365

3730

S32.5

ICD-10 Finland

Fracture of pubis

2.0

6.8

313

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.2

6.8

128

Kela drug reimbursment

Cancers of female genital organs

0.4

6.8

497

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

6.8

368

2118

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.0

6.7

325

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.2

6.7

278

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

6.7

293

3083

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.0

6.7

337

Angiography of the heart and coronary arteries

1.2

6.7

927

6022

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.7

6.7

123

D07AC01

ATC

betamethasone; topical

1.1

6.7

2751

19486

B01AC07

ATC

dipyridamole; systemic

1.2

6.7

736

4668

R5120

NOMESCO Finland

Preparation of an aid

1.4

6.7

257

1389

Q90.9

ICD-10 Finland

Down syndrome, unspecified

62.3

6.6

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.6

6.6

180

901

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

6.6

421

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

6.6

228

F0010, G308

ICD-10 Finland

+∞

6.6

F0022, G301

ICD-10 Finland

+∞

6.6

P76

ICPC

Depressive disorder

1.6

6.6

175

872

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.6

6.6

164

805

N81.6

ICD-10 Finland

Rectocele

0.7

6.6

216

2377

359

Kela drug reimbursment

Mirabegroni

2.2

6.6

238

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.9

6.6

357

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.7

6.5

125

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.5

6.5

640

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.4

6.5

515

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.5

6.5

641

N80

ICPC

Head injury other

1.8

6.5

116

516

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

6.5

422

4206

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

5.0

6.5

T89

ICPC

Diabetes insulin dependent

1.6

6.5

158

769

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

0.7

6.5

211

2325

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

2.7

6.5

126

G47.3

ICD-10 Finland

Sleep apnoea

0.8

6.5

953

8717

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

7.3

6.5

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.1

6.5

3142

22470

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

6.4

894

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

6.4

590

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

6.4

682

6123

FHL

Radical surgery

1.3

6.4

451

2702

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

6.4

187

2098

AA1BG

SPAT

2.9

6.4

H04AA01

ATC

glucagon; nasal, parenteral

2.0

6.4

295

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.4

6.4

543

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

6.4

134

1597

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.6

6.3

1000

5509B

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]

1.4

6.3

253

1380

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.3

294

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

6.3

1140

SPAT1063

SPAT

Suctioning of mucus from airways

4.2

6.3

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

5.1

6.3

B01AB05

ATC

enoxaparin; parenteral

0.9

6.3

2285

19578

A07

ICPC

Coma

2.9

6.3

101

DJA10

NOMESCO Finland

Biopsy of septum of nose

5.4

6.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

6.2

125

1506

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

0.2

6.2

249

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.3

6.2

192

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

0.5

6.2

801

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

6.9

6.2

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

1.6

6.2

139

663

T68

ICD-10 Finland

Hypothermia

2.5

6.2

139

G20

ICD-10 Finland

Parkinson disease

1.4

6.2

353

2047

R26

ICD-10 Finland

Abnormalities of gait and mobility

3.0

6.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

0.6

6.2

101

1274

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

6.2

6405

47672

N05AN01

ATC

lithium; oral

1.8

6.2

395

NF3AA

NOMESCO Finland

Femur X-ray examination

1.6

6.2

159

787

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.4

6.1

549

D17

ICPC

Incontinence of bowel

2.0

6.1

298

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.8

6.1

411

P03

ICPC

Feeling depressed

1.4

6.1

261

1440

U29

ICPC

Urinary symptom/complaint other

1.5

6.1

223

1196

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.2

6.1

245

G03FB01

ATC

norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

6.1

948

S01.3

ICD-10 Finland

Open wound of ear

1.8

6.1

380

Z74.1

ICD-10 Finland

Need for assistance with personal care

7.3

6.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

6.0

1619

11131

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.2

6.0

200

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

1.8

6.0

419

J01CA04

ATC

amoxicillin; systemic

1.1

6.0

6542

48775

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

6.0

540

3343

NG1AA

SPAT

0.4

6.0

425

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

707

390

13.67

307.65

1.0

56.7

39.0

ng/l

10.21

505

224

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

698

391

13.46

307.65

1.0

413.6

285.9

ng/l

13.08

505

229

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

707

390

13.67

307.65

1.0

549.8

727.7

ng/l

10.23

497

220

(3019309) Folate [Moles/volume] in Red Blood Cells

6025

22843

2.49

307.65

1.9

1.8

1191.6

1157.3

nmol/l

1.87

4453

16699

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

672

1189

4.22

221.11

1.2

1.3

15.2

22.6

e6/l

0.37

530

947

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

672

1189

4.22

221.11

1.3

1.4

294.7

1155.9

e6/l

3.56

542

1001

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

738

1411

3.92

219.56

1.2

1.3

513.4

577.1

mg/l

0.84

669

1336

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

663

1222

4.05

206.88

1.1

1.2

3.8

3.9

mmol/l

0.99

620

1132

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4223

19341

1.80

196.55

2.9

3.1

2.5

mmol/l

15.15

3616

16544

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7621

41966

1.62

172.10

2.4

2.2

90.9

92.9

pmol/l

2.97

3953

21487

(3044290) Cell count panel - Cerebral spinal fluid

569

1103

3.83

165.66

1.2

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6056

32226

1.59

150.64

2.5

3.2

2.3

2.4

mmol/l

0.33

5081

26895

(3021960) Folate [Moles/volume] in Serum or Plasma

4996

25607

1.61

143.51

1.7

1.6

20.2

20.3

nmol/l

0.03

4406

21388

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4354

21716

1.63

138.77

1.8

2468869.7

23256797.3

pmol/l

6.03

3484

17019

(3009466) Valproate [Moles/volume] in Serum or Plasma

436

800

4.02

136.44

3.1

3.7

312.4

328.6

umol/l

1.27

343

658

(3023410) Appearance of Cerebral spinal fluid

311

476

4.79

121.27

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

3210

33054

0.62

115.34

2.2

2.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

9696

59531

1.48

107.35

6.1

5.6

3536.7

1409.4

e6/l

2.20

253

1042

(3024561) Albumin [Mass/volume] in Serum or Plasma

7150

42033

1.43

93.60

3.6

4.5

34.4

34.0

g/l

5.31

6355

38312

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1740

19760

0.59

88.84

1.5

1.6

1.2

1.3

mmol/l

2.00

1478

16032

(3026008) Bacteria identified in Urine by Culture

5876

33636

1.42

86.95

3.9

3.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2530

12420

1.56

79.23

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2517

12488

1.54

74.73

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3191

30811

0.68

74.70

3.3

3.9

10.7

10.1

mg/mmol

0.24

1933

19296

(3023368) Bacteria identified in Blood by Culture

5224

30007

1.39

71.69

3.9

4.3

—

(3012516) Albumin [Mass/volume] in Urine

2990

28975

0.68

70.29

2.7

3.2

435.3

400.1

mg/l

0.15

1886

18368

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3393

18127

1.45

69.60

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

3006

29041

0.69

69.25

2.6

3.1

6.9

6.7

mmol/l

2.41

2345

23467

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7331

44675

1.35

68.38

4.5

5.9

1.2

mmol/l

11.05

6441

39705

(3019150) Specific gravity of Urine by Refractometry

3428

18531

1.43

65.35

5.4

5.0

1.0

kg/l

1.38

555

3103

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8883

71876

0.74

64.14

3.9

4.8

1.4

mmol/l

0.12

7585

63163

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1409

6340

1.67

61.90

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8566

69525

0.75

61.63

3.5

4.3

1.2

mmol/l

3.49

7212

60364

(3018418) pH of Serum or Plasma

5038

29349

1.36

60.57

3.0

4.0

7.4

1.57

757

5622

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

848

10618

0.55

59.60

1.2

16.2

16.0

u/ml

0.02

223

3431

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5809

34699

1.34

58.60

2.1

2.2

78.1

81.0

nmol/l

9.91

4873

29608

(3016018) Differential panel - Cerebral spinal fluid

246

559

3.21

56.60

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9080

72715

0.76

55.60

4.0

4.9

4.3

mmol/l

1.52

7821

64478

(1761868) Lipid panel - Serum or Plasma

1755

18152

0.66

55.23

3.2

3.7

—

(4035726)

590

7994

0.51

53.66

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7884

49547

1.31

53.57

5.0

6.6

1.2

mmol/l

24.13

6388

41074

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

967

11312

0.59

52.15

1.2

1.3

42.3

43.0

iu/ml

0.05

297

3427

(3017181) Myelocytes/100 leukocytes in Blood

580

7694

0.53

49.05

3.1

3.7

1.2

0.9

0.65

162

2388

(3021440) Promyelocytes/100 leukocytes in Blood

541

7321

0.52

48.79

3.1

3.7

0.2

0.1

0.77

148

2233

(3002179) Metamyelocytes/100 leukocytes in Blood

502

6906

0.51

47.65

2.9

3.6

0.7

0.6

0.18

107

1660

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6275

38805

1.28

45.06

4.6

60.9

92.3

ng/l

1.51

4982

31267

(3037522) Nuclear Ab [Titer] in Serum

728

8805

0.58

44.19

1.2

1.3

460.8

529.6

titre

0.61

142

2082

(3025159) Blasts/100 leukocytes in Blood

511

6752

0.53

42.39

3.1

3.7

0.1

0.5

1.79

126

1843

(3003338) MCHC [Mass/volume]

8948

58186

1.27

40.68

26.4

26.5

329.8

330.2

g/l

3.26

8717

57443

(3021589) Normoblasts [#/volume] in Blood

4098

35478

0.77

39.79

9.2

10.9

0.0

e9/l

1.50

3290

28714

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

492

6426

0.54

39.14

1.3

—

(3002256) Pathology report gross observation

1083

11565

0.65

38.29

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9627

75189

0.79

36.70

4.6

5.6

2.4

2.5

mmol/l

2.52

8321

66472

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9103

71496

0.80

36.12

18.5

18.9

66.8

67.4

ml/min/173m2

2.44

7309

59585

(3022145) Colonoscopy Study observation

793

8884

0.62

34.74

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2571

23334

0.75

34.52

2.4

3.0

8755.5

7327.7

umol/l

0.57

2009

19316

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5236

32416

1.25

34.16

2.5

2.1

—

(3003694) ABO and Rh group [Type] in Blood

1969

18436

0.74

32.52

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4777

39958

0.80

32.48

4.0

4.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

761

3444

1.63

32.13

1.2

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11433

77369

1.27

31.95

19.6

19.4

31.9

28.1

mg/l

21.53

9790

64893

(40768797) Stomach Pathology biopsy report

1145

11687

0.68

31.68

1.2

1.3

—

(40761535) Cells panel - Urine sediment

1563

8327

1.40

29.92

3.8

—

(4010399)

515

6103

0.60

28.37

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4762

29637

1.23

28.13

2.2

2.1

254.3

222.2

u/l

1.64

4380

27446

(3029937) Albumin [Presence] in Urine by Test strip

3786

23001

1.25

27.83

5.2

4.8

0.0

estimate

1.15

840

7427

(4034850)

579

2540

1.67

27.59

13.2

13.8

—

(3019069) Monocytes/100 leukocytes in Blood

4702

38939

0.81

27.51

4.7

6.0

8.9

9.0

0.64

4194

35665

(3006504) Eosinophils/100 leukocytes in Blood

4678

38746

0.81

27.36

4.5

5.6

2.8

0.50

4169

35396

(3018010) Neutrophils/100 leukocytes in Blood

4683

38772

0.82

27.25

4.6

5.6

60.8

59.6

7.46

4176

35444

(40760892) CBC W Ordered Manual Differential panel - Blood

1670

15654

0.74

27.19

3.5

4.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3390

20382

1.26

27.18

4.6

4.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

551

6326

0.61

26.58

1.5

1.6

—

(3022096) Basophils/100 leukocytes in Blood

4560

37763

0.82

26.30

4.4

5.6

0.6

2.03

4060

34543

(3037467) Urinalysis macro (dipstick) panel - Urine

8958

59575

1.21

26.11

5.2

5.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2801

16532

1.27

26.07

29.8

33.1

1.6

1.5

inr

0.80

203

2241

(3002030) Lymphocytes/100 leukocytes in Blood

4796

39482

0.82

25.92

4.7

5.9

23.9

24.9

7.49

4233

35912

(3000492) Spirometry study

474

5536

0.61

24.53

1.5

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4957

31300

1.21

24.50

5.2

4.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1184

11499

0.72

24.05

2.6

3.7

20.3

22.2

ug/l

0.11

956

9609

(3006315) Basophils [#/volume] in Blood

5047

41149

0.83

24.02

4.2

5.3

0.0

e9/l

1.32

4221

34524

(3001604) Monocytes [#/volume] in Blood

5014

40846

0.83

23.46

4.2

5.3

0.6

e9/l

0.69

4176

34224

(3013115) Eosinophils [#/volume] in Blood

5215

42299

0.83

23.16

4.3

5.5

0.2

e9/l

0.50

4375

35967

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

558

6196

0.64

23.15

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

356

4361

0.58

22.26

1.8

1.9

1.7

1.4

g/l

0.40

280

3840

(3013512) EKG study

3461

29073

0.82

21.94

4.4

4.8

—

(3019198) Lymphocytes [#/volume] in Blood

5165

41731

0.84

21.32

4.4

5.4

1.8

1.9

e9/l

1.38

4345

35560

(3005719) IgG [Mass/volume] in Serum or Plasma

484

5437

0.63

21.14

2.5

2.7

11.0

10.8

g/l

0.31

405

4907

(3015736) pH of Urine

5161

33056

1.19

20.99

4.4

4.1

—

5.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

265

3459

0.55

20.88

2.9

4.1

216.0

97.1

u/ml

1.10

248

3298

(3013650) Neutrophils [#/volume] in Blood by Automated count

5993

47759

0.84

20.87

5.8

8.2

4.7

4.5

e9/l

9.99

5078

40915

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1176

11189

0.74

20.70

4.3

5.0

34.5

34.2

0.30

690

7046

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10336

70308

1.19

20.34

4.8

5.0

2.0

2.1

mu/l

3.40

9121

61855

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1292

7092

1.34

20.19

1.8

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1296

12098

0.75

19.94

1.4

1.5

2.8

g/l

0.05

581

6495

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4323

27366

1.20

19.74

2.3

2.4

3.1

3.2

mg/l

2.38

3512

22984

(3013139) Helicobacter pylori Ag [Presence] in Stool

449

5005

0.64

18.92

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

6318

41430

1.17

18.75

4.7

4.4

0.0

estimate

0.00

940

7908

(40761511) CBC panel - Blood by Automated count

11249

77325

1.19

18.34

18.9

19.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1414

12900

0.77

18.21

2.6

3.6

247.7

251.8

u/l

0.43

1238

12018

(3009445) Proteinase 3 Ab [Units/volume] in Serum

349

4052

0.61

17.60

1.3

1.5

37.2

19.3

u/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

241

3071

0.56

17.48

1.5

1.6

38.0

38.2

u/l

0.04

184

2519

(3019832) Treponema pallidum Ab [Presence] in Serum

323

1372

1.71

17.46

1.1

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

202

2670

0.54

16.67

1.5

1.4

36.4

16.5

iu/ml

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11765

81388

1.19

16.65

23.6

139.7

139.4

mmol/l

22.09

11289

79076

(3023103) Potassium [Moles/volume] in Serum or Plasma

11772

81457

1.19

16.51

23.7

23.8

4.0

mmol/l

0.99

11268

79027

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8553

57732

1.16

16.43

3.7

4.0

15.2

15.3

pmol/l

0.91

7399

50443

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

520

2544

1.49

15.64

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

3557

29093

0.85

15.53

2.3

2.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

519

2544

1.49

15.47

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

6338

41988

1.15

15.30

4.7

4.5

0.0

estimate

1.08

911

7800

(3013826) Glucose [Moles/volume] in Serum or Plasma

7988

53813

1.15

15.17

4.4

4.8

7.1

6.9

mmol/l

9.38

7492

50612

(42870588) Differential panel, method unspecified - Blood

3635

29633

0.85

15.16

4.0

5.3

—

(3000494) Fungus identified in Specimen by Culture

969

9080

0.75

15.11

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

261

3121

0.60

14.90

1.6

143.5

231.6

titre

0.98

154

(3010813) Leukocytes [#/volume] in Blood

11828

82078

1.18

14.83

27.5

28.7

7.3

7.0

e9/l

7.07

11208

78848

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9562

72611

0.87

14.65

6.3

7.0

42.4

41.4

mmol/mol

14.99

8332

64866

(3035941) MCH [Entitic mass]

11820

82059

1.18

14.49

27.4

28.5

30.4

1.22

11374

80209

(3026361) Erythrocytes [#/volume] in Blood

11820

82063

1.18

14.46

27.5

28.7

4.2

4.3

e12/l

43.11

11188

78797

(3007461) Platelets [#/volume] in Blood

11818

82054

1.18

14.41

27.5

28.7

235.1

236.8

e9/l

1.81

11254

79185

(3024731) MCV [Entitic volume]

11819

82063

1.18

14.40

27.4

28.6

92.0

0.27

11378

80215

(3000963) Hemoglobin [Mass/volume] in Blood

11820

82073

1.18

14.38

27.7

28.9

127.7

130.1

g/l

52.75

11357

80240

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

202

2556

0.56

14.34

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

162

591

1.99

14.25

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

791

4272

1.35

13.71

1.5

1.6

1.7

0.46

643

3386

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2639

21936

0.84

13.64

2.2

2.5

—

(3006270) Folate [Moles/volume] in Blood

228

944

1.75

13.60

1.2

307.8

307.9

nmol/l

0.00

174

697

(40768443) Skin Pathology biopsy report

391

4179

0.67

13.48

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

141

1945

0.52

13.48

1.6

1.7

13.1

12.5

mg/l

0.32

120

1742

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1735

10389

1.23

13.45

2.5

5.1

6.1

ug/l

2.21

1282

8678

(3021601) Nitrite [Presence] in Urine by Test strip

6223

41425

1.14

13.38

6.0

0.0

estimate

0.50

909

7887

(3020779) Urea [Moles/volume] in Serum or Plasma

1073

9754

0.78

13.20

4.0

5.8

11.8

12.2

mmol/l

0.74

967

9079

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

166

2156

0.55

12.98

1.8

2.8

266.8

743.4

u/ml

1.72

143

1948

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1207

6966

1.27

12.93

5.0

6.3

24.5

24.6

mmol/l

0.15

1139

6488

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

546

5410

0.72

12.34

1.3

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

205

2479

0.59

12.31

1.2

0.5

1.0

u/ml

1.14

245

(3052592) Norovirus Ag [Presence] in Stool

240

2.47

12.29

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1342

7889

1.25

12.28

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1407

0.47

12.05

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

285

3174

0.64

12.03

1.2

1.3

271.9

247.2

u/ml

0.24

247

2867

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

1687

0.51

12.02

1.2

4.7

4.8

u/ml

0.04

290

(40768793) Breast Pathology biopsy report

119

1663

0.51

11.92

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

120

1668

0.52

11.82

1.2

4.3

5.4

u/ml

—

188

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

734

6901

0.76

11.68

2.9

3.0

56.1

55.9

ml/min/173m2

0.05

306

3232

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

983

0.38

11.63

1.4

1.5

—

(4094501)

146

1901

0.55

11.57

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

139

1833

0.54

11.51

3.8

3.4

2.2

1.5

0.89

104

1375

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

161

2029

0.57

11.35

1.2

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

135

1782

0.54

11.23

1.2

3.4

43.4

u/ml

—

101

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

694

0.28

11.23

1.7

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

165

2057

0.57

11.18

1.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

116

411

2.05

11.16

1.0

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

168

2078

0.58

11.06

1.4

1.1

g/l

0.14

153

1940

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1332

0.48

11.00

3.6

3.5

212.2

2597.2

iu/ml

1.07

190

(40768795) Lymph node Pathology biopsy report

840

0.35

10.96

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

112

1551

0.52

10.94

1.5

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1588

13556

0.83

10.80

3.4

5.0

1.0

mmol/l

0.91

1369

12270

(3017143) Hepatitis C virus Ab [Presence] in Serum

535

5201

0.73

10.73

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3145

20213

1.16

10.70

4.4

218.5

439.7

ng/l

3.47

2834

17999

(3009542) Hematocrit [Volume Fraction] of Blood

9343

64300

1.13

10.66

22.1

21.3

36.7

37.2

3.25

4946

36150

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

139

537

1.88

10.49

1.1

—

3.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

148

1865

0.57

10.47

2.3

2.1

208.7

214.4

0.34

132

1756

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

1443

0.51

10.46

1.2

2.2

5.6

u/ml

—

121

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

166

2026

0.59

10.40

1.3

1.4

0.2

g/l

0.28

151

1886

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

364

3748

0.69

10.35

2.0

2.9

329.7

2703.3

u/ml

2.28

273

3170

(3045142) Bone marrow Pathology biopsy report

1082

0.44

10.26

1.2

—

(3042631) Mycobacterium sp identified in Specimen

131

1697

0.55

10.25

2.3

2.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1018

0.43

10.17

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

785

7181

0.78

10.12

1.8

1.9

168.3

177.0

ug/g

0.22

558

5407

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

395

3993

0.71

10.12

2.7

—

(3014271) Vancomycin [Susceptibility]

199

866

1.67

10.06

3.4

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

153

1885

0.58

9.97

1.3

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

182

2141

0.61

9.86

1.8

2.1

3.6

3.7

g/l

0.36

165

2018

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

165

686

1.74

9.85

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1917

11928

1.18

9.78

10.4

9.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

373

1887

1.44

9.61

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10004

75026

0.89

9.58

4.6

5.4

6.2

6.1

mmol/l

5.33

8519

65567

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

173

2.51

9.38

1.3

1.2

34.8

21.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

167

1977

0.61

9.31

1.7

1.9

90.3

87.1

1.26

153

1862

(3017354) Segmented neutrophils/100 leukocytes in Blood

1131

0.49

9.10

3.0

3.5

59.1

60.1

0.11

675

(3043409) Potassium [Moles/volume] in Arterial blood

601

3334

1.31

8.78

3.2

3.9

mmol/l

0.08

547

3091

(3021879) Hepatitis B virus core Ab [Presence] in Serum

320

3268

0.70

8.74

1.2

—

(21494755) Public health laboratory ask at order entry panel

669

0.35

8.73

1.3

1.4

—

(3008898) HLA-B27 [Presence]

1063

0.49

8.66

1.0

—

(4027681)

183

2.37

8.38

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1017

0.49

8.28

1.6

2.0

679.2

1650.0

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

139

1667

0.60

8.23

1.1

161.7

151.7

titre

0.03

106

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

264

0.16

8.22

1.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

929

0.47

8.06

1.1

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

257

2.11

8.00

2.9

2.8

27.1

29.6

umol/l

1.20

190

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

126

1524

0.59

7.74

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

972

0.50

7.71

1.6

1.5

0.8

g/l

0.26

730

(40757373) Influenza virus identified in Isolate

209

2.22

7.70

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1078

0.53

7.51

1.2

1.3

0.1

0.3

nmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

141

1645

0.62

7.49

2.6

3.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1074

0.53

7.43

1.2

1.3

0.7

nmol/l

0.61

1019

(4281824)

878

0.48

7.34

1.2

—

(40768800) Prostate Pathology biopsy report

201

2161

0.67

7.32

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1920

15657

0.87

7.25

2.1

2.6

0.8

mmol/l

0.66

1672

14275

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

194

2096

0.66

7.25

2.3

2.5

1.8

1.9

mg/l

0.84

155

1826

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

998

0.52

7.22

1.2

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1026

0.53

7.21

2.0

2.2

171.5

904.5

u/ml

1.29

1009

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

235

2444

0.69

7.19

1.8

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

329

3228

0.73

7.12

1.1

65.8

130.6

iu/ml

3.54

102

1049

(3042936) Bacteria identified in Isolate by Culture

1627

13393

0.86

6.99

1.8

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2313

18584

0.88

6.97

3.0

3.5

0.9

ug/l

0.16

1669

13823

(3034860) Kappa light chains.free [Mass/volume] in Serum

447

4175

0.77

6.86

2.6

3.0

61.7

84.5

mg/l

0.67

352

3390

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

264

2.00

6.83

1.3

1.5

77.9

97.4

umol/l

0.54

158

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

447

4163

0.77

6.72

2.6

3.0

48.0

53.0

mg/l

0.29

356

3376

(3023419) Bacteria identified in Sputum by Culture

112

1338

0.60

6.62

1.7

2.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

288

1.93

6.57

1.1

39.4

45.9

mg/l

0.71

247

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

615

0.42

6.55

1.2

—

(3011412) CD3 cells [#/volume] in Blood

612

0.42

6.47

2.9

1.7

1.0

e9/l

0.12

389

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1679

13716

0.87

6.47

1.2

1.9

1.8

u/ml

0.15

361

3219

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

300

2936

0.73

6.42

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

374

1.80

6.38

1.2

0.7

1.0

promille

1.98

276

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1833

14859

0.88

6.30

2.2

2.6

20.0

20.7

1.36

1357

12398

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1037

0.56

6.27

1.3

1.2

—

17.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

440

4047

0.78

6.03

2.6

3.0

3.5

3.2

ratio

0.10

290

(3020630) Protein [Mass/volume] in Serum or Plasma

1183

9856

0.86

5.95

2.1

2.5

65.3

65.8

g/l

1.17

960

8677

(3013637) Mi-2 Ab [Presence] in Serum

193

0.19

5.73

1.4

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

193

0.19

5.73

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

193

0.19

5.73

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

193

0.19

5.73

1.4

1.1

—

(3036603) Volume of Urine

591

0.45

5.72

2.3

1.5

1815.9

1818.7

0.00

179

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1055

0.59

5.72

1.3

1.2

—

(21494434) Karyotype in Bone marrow

954

0.57

5.71

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

113

497

1.65

5.70

1.2

2.2

mmol/l

0.25

105

447

(3020891) Body temperature

719

4300

1.22

5.69

3.8

4.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

104

1212

0.62

5.62

3.1

3.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

665

0.49

5.60

3.0

3.6

—

(3039000) Anion gap in Blood

403

2261

1.29

5.57

4.2

6.0

11.3

mmol/l

0.03

368

2013

(3018572) Chloride [Moles/volume] in Blood

403

2261

1.29

5.57

4.2

6.0

104.8

mmol/l

0.02

368

2013

(3018095) Leukocytes [#/volume] in Urine

4966

33779

1.09

5.57

4.2

4.1

186.4

136.6

e6/l

1.30

3649

24982

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1164

0.61

5.56

1.2

65.7

47.1

u/ml

—

136

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

195

1995

0.70

5.54

1.4

1.5

46.9

5.2

iu/ml

1.05

519

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

1224

0.62

5.51

1.2

1.3

—

(3011985) Renin [Units/volume] in Plasma

998

0.58

5.49

1.1

1.3

29.3

52.8

mu/l

1.75

869

(3024522) Salmonella sp identified in Specimen by Organism specific culture

108

1237

0.63

5.43

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

107

1228

0.63

5.43

1.2

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

660

5736

0.82

5.42

4.6

7.1

24.2

24.4

mmol/l

0.65

577

5238

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

1261

0.63

5.38

1.2

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

131

1435

0.66

5.36

1.5

1.7

17.0

23.6

ug/l

2.33

126

1392

(3025468) Yersinia sp identified in Specimen by Organism specific culture

107

1224

0.63

5.35

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

107

1224

0.63

5.35

1.2

1.4

—

(3045424) Erythrocytes [Presence] in Urine

129

1416

0.65

5.33

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

400

2259

1.29

5.28

1.2

—

(40768441) Liver Pathology biopsy report

470

0.41

5.24

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

307

2901

0.76

5.24

1.8

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

404

2288

1.28

5.22

1.2

—

(36304419) Bacteria [Presence] in Urine

3878

26152

1.09

5.21

3.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

682

5880

0.83

5.16

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

404

2292

1.28

5.15

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

1283

0.64

5.15

1.4

—

(3047181) Lactate [Moles/volume] in Blood

539

3171

1.24

5.04

4.1

5.4

1.4

1.3

mmol/l

0.58

484

2805

(21494814) CD8 cells/100 lymphocytes in Specimen

277

0.26

5.00

3.9

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

653

3922

1.21

4.99

3.1

3.7

1.4

mmol/l

0.22

644

3843

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

100

1134

0.63

4.86

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

113

1245

0.65

4.80

3.0

3.5

32.4

46.6

u/ml

1.09

104

1202

(3035637) Corticotropin [Mass/volume] in Plasma

853

0.58

4.80

1.1

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

539

4713

0.82

4.75

1.9

2.2

3.8

g/l

0.34

346

3206

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

776

0.57

4.73

1.4

1.8

4.4

4.9

mg/l

0.55

725

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

243

1303

1.35

4.68

1.7

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

112

1229

0.66

4.68

1.4

1.5

71.9

64.2

1.65

761

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

270

1.79

4.68

1.0

1.1

285.9

329.5

mg/l

0.82

237

(3017732) Neutrophils [#/volume] in Blood

616

5307

0.83

4.66

3.2

3.3

4.4

4.3

e9/l

0.33

402

3558

(3004588) Protein electrophoresis panel - Serum or Plasma

1002

8292

0.86

4.64

2.1

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

342

0.36

4.64

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

898

0.60

4.62

1.3

1.2

114.9

127.4

u/ml

0.51

206

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2411

15979

1.11

4.61

3.2

2.8

2.7

e6/l

0.14

1405

9058

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

543

4727

0.82

4.59

1.9

2.2

7.6

7.5

g/l

0.14

357

3334

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

543

4722

0.82

4.54

1.9

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2271

17856

0.90

4.53

1.5

1.7

1.8

1.6

mg/l

1.54

1741

14107

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1987

15729

0.90

4.52

2.0

2.5

2.2

g/l

3.31

1735

14278

(3022621) pH of Urine by Test strip

995

6253

1.16

4.51

3.9

3.6

—

(3002582) Erythrocytes [#/volume] in Urine

4423

30153

1.08

4.50

3.7

3.6

111.9

116.0

e6/l

0.05

3466

23574

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

377

0.40

4.45

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

212

2055

0.74

4.40

1.3

1.5

30.0

31.0

g/l

0.56

188

1820

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

509

4438

0.82

4.39

1.9

2.2

10.4

10.3

g/l

0.15

379

3594

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

188

0.27

4.38

4.3

1.8

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

105

2.27

4.37

1.1

1.2

24.9

49.7

1.72

(3024354) Oxygen [Partial pressure] in Venous blood

1356

8728

1.13

4.35

2.4

3.1

4.1

4.3

kpa

4.37

1288

8401

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

928

0.62

4.34

1.2

1.3

—

nmol/l

—

(3019060) Gas panel - Arterial blood

1186

7571

1.14

4.32

3.5

4.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

924

0.62

4.27

1.1

1.2

236.3

251.6

pmol/l

0.27

693

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

460

0.47

4.26

2.5

1.7

17.9

15.9

0.27

166

(3023183) Ammonium ion [Moles/volume] in Plasma

318

1799

1.28

4.23

1.5

1.9

27.0

32.2

umol/l

4.18

248

1418

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

602

3651

1.20

4.21

1.9

2.2

1022.4

551.0

ug/l

0.71

558

3447

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

497

0.49

4.21

1.1

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

497

0.49

4.21

1.1

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

497

0.49

4.21

1.1

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

1320

0.69

4.20

1.2

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

626

0.55

4.12

1.0

1.1

122.3

115.0

1.07

532

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

862

0.62

4.11

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

279

0.34

4.10

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

453

0.48

4.09

2.5

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

434

2557

1.23

4.08

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

346

3115

0.80

4.08

2.7

3.1

—

(4146454)

111

1183

0.67

4.07

2.3

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

377

1.61

4.04

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

308

0.37

4.02

1.6

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

379

0.44

3.99

1.1

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

379

0.44

3.99

1.1

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

502

4338

0.83

3.97

2.0

2.3

3.2

3.1

g/l

0.32

348

3266

(3027135) IgG subclass 1 [Mass/volume] in Serum

607

0.56

3.92

1.2

1.3

6.5

7.2

g/l

0.58

423

(3028192) IgG subclass 2 [Mass/volume] in Serum

607

0.56

3.92

1.2

1.3

2.6

2.9

g/l

0.80

430

(3024139) IgG subclass 3 [Mass/volume] in Serum

607

0.56

3.92

1.2

1.3

0.4

0.5

g/l

0.16

430

(3048929) Epstein Barr virus Ab [Presence] in Serum

1070

0.67

3.91

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

171

1679

0.73

3.91

1.2

1.3

41.4

40.8

u/l

0.02

144

1434

(3000093) Morphology [Interpretation] in Blood Narrative

101

1087

0.67

3.91

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

734

0.60

3.90

1.1

1.2

1.6

5.7

u/ml

2.82

231

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

705

0.59

3.87

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

293

2669

0.79

3.85

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

247

0.32

3.83

3.6

1.7

—

(1002224) Polysomnography panel

106

1124

0.68

3.81

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

351

0.43

3.80

1.9

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

701

0.60

3.79

1.1

1.2

5.2

4.2

u/ml

0.19

309

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

278

1.69

3.78

2.5

2.0

57.7

57.9

umol/l

0.02

205

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

723

6030

0.86

3.77

2.5

2.6

—

(3021788) Differential panel - Synovial fluid

183

1766

0.74

3.75

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

495

0.52

3.73

1.1

1.5

—

(4268621)

456

0.51

3.72

2.0

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

2.19

3.70

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

136

1370

0.71

3.68

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

740

0.61

3.67

1.3

13.0

12.9

u/l

0.02

571

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

819

0.63

3.66

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

819

0.63

3.66

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

819

0.63

3.66

1.2

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

502

4302

0.84

3.65

2.1

2.6

0.4

0.3

u/ml

0.56

292

2448

(3008116) Ketones [Moles/volume] in Urine by Test strip

164

1.90

3.64

1.3

—

(4062490)

611

0.58

3.63

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1666

10970

1.11

3.62

3.3

3.2

261.8

283.6

ng/l

0.98

1517

10094

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

145

0.25

3.61

13.8

12.5

5.7

5.4

mmol/l

—

145

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

489

0.53

3.60

1.0

1.1

98.1

90.0

1.33

443

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1638

0.74

3.58

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

945

0.66

3.57

1.0

—

(3022313) Gas panel - Capillary blood

577

4875

0.85

3.56

3.1

4.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

259

0.36

3.56

1.5

2.6

—

(4306422)

643

0.59

3.54

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

113

1166

0.70

3.53

4.7

3.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

776

0.63

3.52

1.3

1.2

25.0

44.5

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

378

0.48

3.48

1.2

1.1

0.4

1.0

u/ml

—

137

(3014111) Lactate [Moles/volume] in Serum or Plasma

1411

9232

1.11

3.46

3.3

5.5

1.5

1.4

mmol/l

5.69

1343

8792

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2540

17097

1.09

3.44

2.9

3.0

1.5

e6/l

0.15

1518

10102

(3012565) Volume of 24 hour Urine

434

0.51

3.44

1.8

2.2

1676.4

1795.9

0.24

363

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

404

0.50

3.41

2.2

1.9

373.3

538.0

e6/l

—

176

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

840

0.65

3.41

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

580

0.58

3.38

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

383

0.49

3.37

1.3

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

138

1365

0.73

3.37

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

131

1306

0.72

3.36

1.3

1.4

6.3

6.4

mmol/l

0.24

111

1222

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

624

0.60

3.35

1.2

7.3

8.1

mmol/l

1.08

393

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

569

0.58

3.34

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

569

0.58

3.34

1.2

1.4

—

(4015189)

311

0.44

3.30

1.7

2.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4814

36305

0.94

3.29

3.0

3.3

2323.8

2090.2

ng/l

2.19

4027

31768

(3028626) Oxygen [Partial pressure] in Capillary blood

303

2695

0.81

3.28

2.4

2.9

7.4

7.7

kpa

2.49

290

2479

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

943

0.68

3.25

1.4

1.5

15.8

26.6

5.37

587

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

258

1.65

3.22

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

652

0.62

3.20

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

479

0.56

3.19

1.0

—

(3017569) Oxygen content in Arterial blood

597

0.60

3.18

2.5

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

861

0.67

3.18

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

223

0.36

3.17

3.1

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

676

0.63

3.15

1.6

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

421

0.53

3.15

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

177

1669

0.76

3.14

2.5

3.5

60.8

59.5

0.64

177

1669

(3025130) Human papilloma virus identified in Specimen

353

0.49

3.13

2.1

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

158

0.32

3.12

1.0

1.4

—

(3012441) Differential panel - Pleural fluid

163

1553

0.75

3.12

1.4

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

797

0.66

3.12

1.0

1.1

262.2

293.4

u/ml

0.47

460

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

145

1404

0.74

3.11

1.2

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

507

4272

0.85

3.08

1.9

2.0

10.0

10.4

nmol/l

0.44

406

3529

(21494890) Protein electrophoresis panel - 24 hour Urine

126

1243

0.73

3.06

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

714

5861

0.87

3.04

1.5

1.6

g/l

0.49

554

4960

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

858

6958

0.88

3.03

2.9

3.8

5.2

kpa

0.45

754

6320

(3009343) pH of Capillary blood

847

6874

0.88

3.02

3.0

3.8

7.4

0.69

107

912

(40768806) Pleura Pathology biopsy report

163

1545

0.76

3.02

1.4

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

461

0.56

3.01

1.2

1.4

3.4

3.5

—

103

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

142

1370

0.75

2.99

1.2

1.3

406.2

409.6

u/l

0.02

127

1291

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

140

1353

0.74

2.98

1.2

1.3

0.8

nmol/l

0.16

113

1100

(3036489) Thrombin time

317

2774

0.82

2.96

1.6

1.7

21.7

22.1

0.26

284

2521

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.05

2.91

2.1

2.3

159.0

133.5

nmol/l

0.79

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

389

0.54

2.86

2.3

1.7

501.3

491.3

e6/l

0.04

336

(3022689) Creatine [Moles/volume] in Urine

221

0.39

2.83

1.3

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

3157

21580

1.07

2.83

2.9

2.8

5.8

5.0

e6/l

2.42

2767

18863

(3019420) Tryptase [Mass/volume] in Serum or Plasma

261

0.44

2.81

1.6

1.5

8.6

10.6

ug/l

0.50

237

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

735

0.67

2.81

1.2

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

822

6644

0.89

2.77

3.0

3.7

1.9

2.1

mmol/l

0.66

584

4886

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

494

0.60

2.75

1.0

1.1

109.3

92.8

u/l

0.52

361

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

355

0.53

2.74

2.0

2.5

36.2

36.4

—

132

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

782

1.33

2.73

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

161

1505

0.77

2.73

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

492

0.60

2.71

1.0

1.1

44.7

32.1

u/l

0.44

350

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

382

0.55

2.71

1.6

1.4

5.3

6.1

u/l

0.77

305

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

296

0.49

2.70

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

823

0.69

2.70

1.1

71.8

601.8

iu/ml

0.75

130

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

470

3932

0.86

2.65

1.9

2.4

1.4

1.2

g/l

0.33

353

3238

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

140

1.81

2.65

3.4

3.0

0.4

0.5

u/field

0.65

140

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

366

1.48

2.63

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

331

0.52

2.63

1.0

1.4

1.7

u/ml

—

136

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

134

1276

0.76

2.62

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

159

1479

0.77

2.61

1.2

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

184

1678

0.79

2.58

1.3

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

354

3022

0.84

2.57

3.3

3.7

1.8

1.6

mmol/l

2.04

344

2963

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

141

771

1.32

2.57

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

979

0.73

2.52

1.1

1.2

58.9

60.9

u/l

0.13

654

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

402

3385

0.85

2.49

1.9

2.3

0.0

g/l

0.92

329

3020

(3019174) dRVVT (LA screen)

0.00

2.48

0.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

151

0.38

2.47

6.0

8.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

576

0.65

2.47

1.1

1.2

233.3

128.6

titre

—

108

(3044009) aPTT.lupus sensitive (LA screen)

0.00

2.45

0.0

1.2

—

(44813793)

341

0.55

2.43

1.0

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9291

65706

1.05

2.43

5.4

7.6

82.2

82.9

u/l

0.43

8407

61198

(3008401) Mugwort IgE Ab [Units/volume] in Serum

322

0.54

2.43

1.0

0.6

1.2

u/ml

—

126

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

229

2023

0.81

2.42

1.2

1.3

—

(3037121) Protein [Mass/volume] in Urine

424

3547

0.86

2.42

2.3

2.8

0.3

g/l

0.01

139

1366

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

102

997

0.74

2.42

1.4

1.3

—

(40768446) Kidney Pathology biopsy report

195

0.41

2.42

1.0

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

503

0.63

2.42

1.3

1.4

2.8

2.6

0.07

415

(1761482) Bacteria [#/volume] in Urine by Culture

420

3514

0.86

2.41

5.1

5.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

113

1085

0.75

2.38

1.6

1.9

3.6

mg/l

1.74

815

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

384

0.58

2.37

1.0

297.2

292.8

mg/l

0.12

333

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

544

0.65

2.36

1.0

1.1

4.3

4.2

u/ml

0.01

100

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

319

0.54

2.36

2.5

2.2

—

(3004775) Volume in Urine collected for unspecified duration

892

0.73

2.35

2.1

645.4

648.4

0.02

560

(3023199) Leukocytes [#/volume] in Pleural fluid

199

1777

0.81

2.35

1.4

1.5

3113.2

2319.7

e6/l

0.32

151

1273

(3016750) Collection duration of Urine

612

0.67

2.34

2.2

1.9

503.4

500.9

min

0.06

421

(3021162) Amylase [Enzymatic activity/volume] in Specimen

126

0.34

2.32

2.3

2.5

1206.8

1601.9

u/l

—

119

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

576

0.66

2.31

1.2

1.4

62.2

67.6

0.49

462

(3004451) EKG impression Narrative

636

0.68

2.31

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

371

1.44

2.31

1.1

—

(3021901) Oxygen saturation in Capillary blood

270

2332

0.83

2.28

2.4

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

879

0.73

2.28

1.2

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

806

5245

1.12

2.28

2.1

2.5

1.2

1.1

1.25

800

5221

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3081

23322

0.94

2.27

2.5

3.0

35.9

36.8

u/l

0.22

2810

21757

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

2.26

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

332

0.56

2.24

2.0

1.8

788.8

1667.7

u/ml

3.96

319

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

276

0.52

2.24

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

304

2592

0.84

2.23

1.1

1.0

1.2

u/ml

—

(3038515) Glucose [Moles/volume] in Venous blood

343

2895

0.85

2.23

3.4

3.8

8.5

7.7

mmol/l

3.89

335

2839

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

833

0.73

2.22

1.2

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

274

2356

0.84

2.22

1.5

1.6

21669.6

14490.7

e6/l

0.92

199

1679

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

187

0.42

2.21

3.6

2.6

—

(4133840)

133

0.38

2.20

1.6

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

112

0.32

2.19

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.13

2.18

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2207

16859

0.94

2.17

2.0

2.5

10.9

11.5

umol/l

3.66

1888

15330

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

618

0.69

2.15

1.2

1.5

—

(3048879) Bone marrow aspiration report

382

0.60

2.15

1.1

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

583

0.68

2.14

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

617

0.69

2.14

1.2

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

381

0.61

2.13

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

433

0.63

2.10

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

141

0.41

2.09

1.0

1.2

—

13.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

248

2138

0.83

2.09

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

432

0.63

2.08

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

432

0.63

2.08

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.26

2.07

1.2

1.1

14.8

11.7

nmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

378

0.61

2.07

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

184

1631

0.81

2.07

1.4

1.5

46580.2

67672.4

e6/l

0.83

113

960

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

0.37

2.06

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

368

0.61

2.05

8.7

5.0

51.3

72.8

2.39

287

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

430

0.64

2.05

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.06

2.03

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

429

0.64

2.03

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

429

0.64

2.03

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

373

3102

0.86

2.03

2.0

2.3

0.0

g/l

0.00

311

2799

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

455

3732

0.88

2.02

1.2

1.3

61.1

55.5

au/ml

0.15

151

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

787

5155

1.11

2.01

2.1

2.5

0.7

2.27

747

4960

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

480

0.66

2.00

1.1

1.2

13.0

12.2

mmol/l

0.30

141

(3040151) Glucose [Moles/volume] in Capillary blood

229

1375

1.21

1.98

10.9

13.6

7.8

7.4

mmol/l

0.73

182

1125

(3020876) Protein [Mass/time] in 24 hour Urine

102

964

0.76

1.98

1.6

1.9

1.8

0.7

g/24h

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

923

0.76

1.98

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

581

0.69

1.97

2.2

41.5

90.9

ug/min

1.67

141

(1001926) Buprenorphine [Presence] in Urine by Screen method

138

1.68

1.95

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

336

2806

0.86

1.95

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

879

0.75

1.94

1.4

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.93

0.0

12.8

—

225.2

—

(3003396) Base excess in Arterial blood by calculation

1852

12601

1.07

1.92

4.0

5.9

1.3

1.2

mmol/l

0.64

1372

9689

(3026470) Cobalt [Mass/volume] in Blood

762

0.74

1.92

1.8

1.9

2.5

4.2

ug/l

2.28

659

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

105

0.34

1.92

1.4

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

827

0.75

1.90

1.1

—

u/ml

—

(3026782) Osmolality of Urine

2992

20663

1.06

1.90

3.0

561.8

540.9

mosm/kgh2o

6.93

2517

17488

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

117

1079

0.78

1.90

1.2

1.3

24.7

12.0

u/l

1.70

102

986

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

267

2263

0.85

1.88

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1535

10386

1.07

1.87

4.5

4.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

683

0.73

1.86

1.5

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

331

0.61

1.85

1.7

1.8

587.5

5183.9

e6/l

0.97

225

(3045788) Cell count panel - Pleural fluid

152

1355

0.81

1.84

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

789

0.75

1.84

1.1

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

4.51

1.83

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

122

0.41

1.83

1.0

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

384

3159

0.87

1.82

2.0

2.3

0.0

g/l

0.23

313

2810

(3047189) Immunofixation for 24 hour Urine

546

0.70

1.82

1.1

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

820

5414

1.10

1.81

3.3

4.3

46.3

45.8

0.24

806

5353

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

302

0.60

1.81

1.7

5261.5

17165.5

e6/l

0.99

173

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

511

0.69

1.80

1.3

—

(3032080) INR in Blood by Coagulation assay

5799

42976

0.96

1.79

10.7

12.1

1.3

1.4

inr

3.07

1410

11504

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

446

3627

0.88

1.78

1.9

2.2

36.6

36.7

g/l

0.13

330

2967

(3034426) Prothrombin time (PT)

160

0.45

1.77

1.0

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

220

1883

0.84

1.76

1.5

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

3969

27665

1.05

1.75

3.5

0.6

0.5

e6/l

1.20

3138

21341

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

501

4041

0.89

1.75

3.4

4.3

25.0

24.9

mmol/l

0.14

423

3621

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

650

0.73

1.74

1.1

—

(3049717) Cytology report of Urine Cyto stain

618

4927

0.90

1.74

2.7

2.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

371

3047

0.88

1.73

2.5

3.1

24.9

25.0

mmol/l

0.27

336

2653

(3011288) Drugs identified in Urine by Screen method

110

1.71

1.73

1.5

1.9

—

(3035880) pH of Pleural fluid

813

0.76

1.72

1.1

1.3

—

(40758358) Immune stain study

0.00

1.72

0.0

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

744

5872

0.91

1.71

3.9

5.8

24.7

24.8

mmol/l

0.22

733

5795

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

118

0.43

1.70

6.9

7.4

—

(4198724)

2.18

1.70

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

231

1961

0.85

1.69

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.91

1.69

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

121

0.42

1.69

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

296

0.61

1.69

1.8

1.9

—

(1616796) Gas panel - Central venous blood

313

2594

0.87

1.68

3.1

3.7

—

(3011648) Oxygen content in Venous blood

637

0.74

1.68

1.2

1.6

9.5

10.3

0.69

637

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

185

0.51

1.67

6.3

8.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.37

1.65

1.0

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4007

27972

1.05

1.65

2.2

2.5

58.5

60.2

u/l

0.96

3635

25556

(3047007) Chlamydophila sp Ab [Presence] in Serum

593

0.73

1.64

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

221

0.55

1.64

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

257

0.59

1.63

1.1

ratio

—

(3000991) Gas panel - Venous blood

1145

8852

0.93

1.63

3.9

6.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.92

1.62

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

220

0.56

1.62

1.6

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

320

2639

0.87

1.61

1.3

1.4

253.2

261.9

ug/g

0.34

170

1629

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1480

10060

1.07

1.61

4.3

6.5

120.1

118.5

g/l

2.28

1422

9690

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

219

0.56

1.60

1.3

52.5

38.7

u/l

—

172

(3027456) Digoxin [Moles/volume] in Serum or Plasma

530

3449

1.11

1.59

3.7

3.2

0.8

nmol/l

0.88

415

2681

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

172

0.50

1.59

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

246

0.59

1.59

5.1

5.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1837

12586

1.06

1.56

4.0

5.9

11.3

11.7

kpa

2.63

1727

11847

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

1.56

0.0

1.3

—

310.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

309

2547

0.87

1.56

2.0

2.2

126.3

99.9

ug/min

0.37

160

1414

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1838

12595

1.06

1.56

4.0

5.9

4.9

5.1

kpa

5.81

1728

11866

(3000012) Reticulocyte production index

726

0.76

1.54

1.7

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.39

1.53

1.4

1.1

—

(3016502) Oxygen saturation in Arterial blood

1643

11229

1.06

1.52

4.1

6.1

94.9

95.1

0.50

1573

10742

(3051593) INR in Capillary blood by Coagulation assay

765

0.77

1.52

7.4

12.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

878

0.79

1.52

1.1

—

(44806420)

434

0.70

1.52

2.3

2.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.38

1.52

1.6

1.2

—

876.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.38

1.52

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

109

981

0.80

1.50

1.2

1.5

14.1

13.6

u/l

0.33

101

937

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

574

0.74

1.49

1.6

1.5

4.3

7.3

u/l

1.10

260

(3011335) Digoxin [Mass/volume] in Serum or Plasma

158

0.50

1.48

2.8

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

1.56

1.48

2.2

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

743

4939

1.09

1.47

2.4

3.7

24.2

24.1

mmol/l

0.14

657

4403

(3033658) Prothrombin time (PT) actual/Normal

2933

21977

0.95

1.46

3.4

4.0

79.7

81.4

3.01

2834

21461

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.50

1.45

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

370

0.68

1.44

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

587

0.75

1.44

1.6

1.7

167.0

186.9

pmol/l

1.16

527

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

352

1.33

1.41

1.6

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

352

1.33

1.41

1.6

2.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

245

0.62

1.38

1.4

1.5

4.8

7.8

—

122

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

525

0.74

1.38

4.1

3.1

—

(3025577) Chromium [Mass/volume] in Blood

737

0.78

1.37

1.9

2.0

1.7

2.3

ug/l

1.50

618

(3028433) Virus identified in Specimen by Culture

270

0.64

1.36

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

183

1.46

1.35

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

313

0.67

1.35

1.6

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

109

0.46

1.34

3.7

1.3

73.4

48.9

pmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

262

1.38

1.34

1.2

1.3

—

(3002032) Base excess in Venous blood by calculation

1541

10563

1.06

1.32

2.6

3.6

2.1

1.9

mmol/l

0.62

1241

8485

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

562

0.76

1.32

1.1

1.2

96.7

94.9

u/l

0.05

488

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

160

0.54

1.31

1.4

1.3

—

2876280.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2004

13843

1.05

1.30

2.0

2.3

1.7

1.8

1.21

1605

11973

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

196

0.59

1.30

1.1

1.0

—

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1543

10584

1.06

1.30

2.6

3.6

5.9

5.8

kpa

1.57

1473

10239

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6383

46996

0.97

1.29

3.9

5.8

12.8

12.5

umol/l

0.87

5821

44378

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

600

0.77

1.28

1.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

735

5716

0.92

1.27

4.1

4.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

144

1.50

1.27

2.3

2.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.31

1.26

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

179

1506

0.86

1.26

2.1

2.2

33.3

29.1

mg/l

0.36

356

(3014007) Fractional oxyhemoglobin in Arterial blood

853

6588

0.93

1.24

4.7

7.2

92.8

93.6

2.42

847

6559

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

193

1.42

1.23

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

263

0.66

1.23

1.0

1.1

8.7

12.0

iu/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

339

0.70

1.21

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.41

1.20

1.2

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.19

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

346

0.71

1.19

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

433

1.27

1.18

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

1.18

0.0

2.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.16

0.0

4.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

196

1.40

1.15

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

171

0.59

1.15

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

102

891

0.83

1.13

2.6

3.1

38.6

31.9

mg/l

0.25

674

(3036670) Protein [Mass/volume] in Synovial fluid

367

0.73

1.12

1.1

1.2

40.0

40.1

g/l

0.02

179

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

433

0.75

1.12

1.0

1.1

1.8

11.6

nmol/l

—

101

(3032057) Clostridioides difficile [Presence] in Stool

284

1.32

1.12

1.5

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

205

0.63

1.12

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

167

1.43

1.11

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

222

0.65

1.11

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1119

8523

0.94

1.09

1.6

2.0

0.2

g/l

0.08

961

7784

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

162

1008

1.16

1.07

1.9

1.6

29.4

26.0

u/ml

0.40

208

(3016879) Cocaine [Presence] in Urine

163

1.42

1.05

1.1

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

717

5528

0.93

1.03

5.2

8.0

—

(3027008) Opiates [Presence] in Urine

170

1.40

1.03

1.1

1.2

—

(3014891) Appearance of Pleural fluid

238

1.34

1.03

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

369

0.74

1.03

1.4

56.9

34.6

iu/l

2.49

308

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

200

0.65

1.02

1.2

1.1

—

8.1

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

147

0.59

1.02

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

171

1.39

1.00

1.1

1.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

1.00

0.0

3.7

—

17.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

309

0.72

1.00

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

309

0.72

1.00

1.0

—

(3006462) Nitrate [Presence] in Urine

480

0.78

0.98

4.7

4.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

224

0.68

0.98

1.2

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

215

1.34

0.98

1.1

1.0

1.2

u/l

2.72

111

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

159

996

1.15

0.98

1.5

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.56

0.98

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

266

0.71

0.98

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

232

0.68

0.97

1.3

2.9

1033.9

u/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

136

0.58

0.97

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

161

1331

0.87

0.96

1.3

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

153

0.61

0.95

1.0

1.3

113.5

114.3

—

131

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

104

0.56

0.95

1.0

2.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

541

0.80

0.94

1.1

1.2

30.5

29.3

u/l

0.06

461

(40758558) Short blood count panel - Blood

2963

20802

1.03

0.92

4.9

6.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

212

0.68

0.92

1.4

0.1

nmol/l

0.11

152

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

151

0.62

0.91

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.48

0.91

8.8

4.7

27.8

61.7

ug/min

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.48

0.91

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

159

0.64

0.89

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

159

0.64

0.89

2.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

343

0.76

0.89

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

243

0.71

0.87

1.4

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

201

1.33

0.87

1.1

—

(40761536) Microorganisms panel - Urine sediment

977

7411

0.95

0.87

4.8

4.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

276

0.73

0.87

1.5

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

942

0.86

0.87

1.3

1.4

139802.1

178168.0

e6/l

0.23

645

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

131

0.61

0.86

1.0

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

1391

10454

0.96

0.85

2.1

2.4

64.9

67.1

e9/l

1.62

1072

7978

(3034274) Bile acid [Moles/volume] in Serum --fasting

307

0.75

0.84

1.1

1.3

5.5

15.9

umol/l

2.17

206

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

568

1.18

0.82

2.5

2.0

1.8

2.6

u/field

0.61

368

(3045716) Anion gap in Serum or Plasma

499

0.81

0.82

1.6

2.0

8.7

9.0

mmol/l

0.31

393

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

223

0.71

0.82

1.5

1.3

29.3

30.7

umol/l

0.41

213

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

168

1366

0.89

0.81

1.3

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.81

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.81

0.0

8.9

—

39.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

214

0.71

0.81

1.0

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

239

0.72

0.81

1.4

12.7

15.7

g/l

0.84

187

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.1

—

0.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.79

0.0

1.2

—

(3025315) Body weight

0.49

0.79

7.0

5.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

0.67

0.78

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

224

1461

1.11

0.78

1.1

10.1

15.6

u/ml

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

143

0.66

0.75

1.1

1.2

17.6

17.1

u/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

160

0.68

0.74

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

161

1036

1.12

0.73

2.5

2.4

2.3

u/field

0.12

332

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

151

1.34

0.72

1.1

1.3

73.1

103.6

ug/l

0.71

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1167

8761

0.96

0.71

3.1

3.9

1.2

mmol/l

0.30

925

7553

(3027944) Amphetamines [Presence] in Urine

164

1.32

0.71

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

200

0.72

0.71

1.1

0.6

0.7

umol/24h

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

200

0.72

0.71

1.3

1.1

219.1

282.3

pmol/l

0.62

133

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.58

0.71

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

196

1.29

0.70

1.1

—

(3015183) Erythrocyte sedimentation rate

132

0.66

0.70

1.0

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

240

0.75

0.69

1.0

1.2

1.5

1.4

mmol/l

0.04

143

(3033705) Calcium.ionized [Moles/volume] in Venous blood

233

1839

0.91

0.68

2.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

137

1112

0.89

0.68

1.3

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.53

0.68

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

148

0.68

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

189

1505

0.91

0.67

1.4

—

(3044007) Cell count panel - Peritoneal fluid

263

0.77

0.67

2.0

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

181

0.72

0.67

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

547

4176

0.94

0.66

2.2

2.4

47.9

28.6

au/ml

—

(3002385) Erythrocyte distribution width [Ratio]

8378

59886

1.02

0.66

23.8

23.7

14.1

0.49

8105

58366

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.80

0.66

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

500

0.84

0.65

1.7

2.3

—

(3037756) Immunofixation for Serum or Plasma

350

2706

0.93

0.64

1.3

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

883

6645

0.96

0.63

4.5

7.1

0.7

8.14

873

6585

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

219

0.76

0.62

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.62

0.0

4.7

—

355.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.62

0.0

1.1

—

8.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.60

0.61

1.4

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.61

0.0

6.9

—

(36303858) Crystals [Presence] in Urine

0.00

0.61

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

643

0.86

0.61

1.1

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

177

0.73

0.60

1.1

1.4

83.6

75.5

0.51

149

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

0.69

0.59

1.0

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1795

13312

0.97

0.59

4.2

5.9

104.4

104.2

mmol/l

1.02

1722

12987

(3038177) Helicobacter pylori Ab [Presence] in Serum

810

0.88

0.59

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.58

1.0

—

(36660697) Celiac disease serology panel - Serum

647

4894

0.95

0.58

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

197

1550

0.92

0.57

1.5

1.6

3.2

4.5

iu/l

1.97

433

(3003181) Sodium [Moles/volume] in Urine

315

2124

1.07

0.57

1.3

63.9

60.6

mmol/l

0.89

258

1704

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.57

1.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.56

0.57

4.2

4.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

128

829

1.12

0.56

1.3

275.7

325.8

titre

0.15

(3033799) Differential panel - Peritoneal fluid

295

0.81

0.56

1.7

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

239

0.78

0.55

1.4

1.5

0.4

ug/l

0.00

124

(3022493) Free Hemoglobin [Mass/volume] in Plasma

420

0.84

0.55

1.1

2.4

61.7

67.1

mg/l

0.29

274

(3045414) Leukocytes [Presence] in Urine

504

3826

0.95

0.54

2.2

2.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

890

6668

0.96

0.54

4.5

7.0

1.5

1.3

8.22

883

6606

(4211845)

512

0.86

0.53

4.4

4.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

112

902

0.90

0.53

1.3

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

186

1.24

0.52

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4665

33222

1.02

0.51

4.7

5.9

6.2

5.0

ug/l

0.40

3921

28974

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

378

0.84

0.51

2.6

2.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

370

0.84

0.51

3.7

6.2

24.2

24.8

mmol/l

0.48

335

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

155

0.74

0.50

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

105

0.69

0.50

1.0

1.3

—

(40762814) Titanium [Mass/volume] in Blood

211

0.79

0.50

2.2

2.0

2.8

3.6

ug/l

1.33

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.58

0.49

1.0

1.1

—

4.0

—

(3016038) Potassium [Moles/volume] in Urine

117

762

1.11

0.49

1.1

36.3

34.9

mmol/l

0.26

634

(3026726) Creatinine [Moles/volume] in Specimen

0.62

0.49

3.1

2.4

215.6

436.2

umol/l

—

(4024509)

134

1062

0.91

0.49

1.6

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

123

804

1.11

0.48

1.3

31.1

61.8

titre

—

(40767503) Oxygen content in Capillary blood by calculation

315

2413

0.94

0.48

2.4

2.6

16.2

15.6

1.62

132

1302

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

194

0.78

0.48

1.3

1.4

116.3

129.8

ng/l

0.27

194

(3002331) Protein [Mass/volume] in Peritoneal fluid

210

0.79

0.48

1.4

1.3

25.7

55.9

g/l

0.60

172

(3020491) Glucose [Moles/volume] in Blood

613

1.12

0.47

2.0

2.4

7.5

7.3

mmol/l

0.29

411

(3014051) Protein [Presence] in Urine by Test strip

306

2080

1.06

0.47

2.4

2.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

255

1.19

0.47

2.6

2.5

7.3

7.5

mmol/l

0.24

172

(37021550) Renin [Units/volume] in Plasma --upright

177

0.77

0.47

1.3

42.5

76.0

mu/l

0.97

122

(3050794) Legionella sp Ab [Presence] in Serum

0.60

0.46

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.40

0.46

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.40

0.46

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.40

0.46

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

145

959

1.09

0.46

1.3

276.5

274.4

mosm/kgh2o

0.41

103

683

(3051387) C reactive protein [Mass/volume] in Capillary blood

329

2246

1.06

0.45

4.0

34.0

30.2

mg/l

0.88

239

1516

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.35

0.45

10.8

13.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

344

2618

0.95

0.44

2.1

2.3

127.2

125.0

g/l

0.93

275

1923

(3013293) Extractable nuclear Ab [Presence] in Serum

0.68

0.44

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

169

1317

0.93

0.44

5.0

5.8

12.9

12.7

mg/l

0.24

144

1173

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

547

0.88

0.43

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

547

0.88

0.43

1.1

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

974

6822

1.03

0.43

2.6

3.2

127.3

125.2

g/l

2.47

947

6655

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

222

0.81

0.43

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

206

0.81

0.42

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

0.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.42

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.42

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.42

0.0

3.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.42

0.0

8.3

—

55.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.42

0.0

1.5

—

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.42

0.0

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.44

0.41

1.9

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

0.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.34

0.40

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1175

8264

1.03

0.40

2.7

3.5

89.1

100.1

ng/l

4.25

932

6793

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.67

0.40

1.1

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

180

0.80

0.39

1.1

1.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2212

15689

1.02

0.39

1.6

1.9

29.7

30.3

3.20

2119

15209

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

115

1.26

0.38

3.9

5.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

148

1.22

0.37

7.1

8.1

13.7

0.01

148

(3020961) Endomysium IgA Ab [Titer] in Serum

332

2514

0.95

0.37

1.1

399.1

236.3

titre

0.52

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.35

0.37

1.0

1.1

0.9

1.1

u/field

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

233

0.84

0.36

1.7

1.6

117.1

112.9

ug/l

0.06

196

(3000285) Sodium [Moles/volume] in Blood

162

1.20

0.36

1.5

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.63

0.36

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

209

0.83

0.36

1.1

1.2

119.6

137.5

nmol/l

0.27

151

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

0.78

0.36

1.4

1.6

44.9

46.0

umol/l

0.05

130

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.71

0.35

1.8

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

153

0.80

0.34

1.6

10.0

9.8

ug/l

0.08

153

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

292

1.14

0.33

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

292

0.86

0.33

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.32

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

478

1.10

0.32

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

426

3192

0.96

0.32

3.6

3.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

405

0.89

0.31

1.1

1.2

nmol/l

0.05

303

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

382

0.89

0.31

5.6

5.8

—

(3051651) Icteric interference index of Serum or Plasma

601

0.91

0.31

3.4

3.6

—

(3019225) pH of Specimen

1424

10476

0.98

0.31

4.0

4.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

111

0.78

0.30

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

289

0.87

0.30

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

644

0.92

0.30

2.1

1.8

280.2

327.5

mu/l

0.67

588

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

165

0.83

0.29

1.1

1.3

38.7

263.4

u/l

—

109

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1112

7866

1.02

0.28

2.1

2.3

31.9

37.8

u/l

3.37

904

6625

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

0.81

0.27

1.3

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

770

5693

0.98

0.27

3.3

2.9

0.5

0.3

e6/l

1.25

753

5595

(3007853) Bacteria identified in Skin by Aerobe culture

1502

10664

1.02

0.27

1.7

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.67

0.26

1.2

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

835

5895

1.02

0.26

2.8

3.4

25.4

25.1

mmol/l

1.42

798

5735

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

429

0.91

0.26

1.3

1280.4

144.0

ug/l

0.98

236

(3041096) Erythrocytes [Presence] in Urine by Automated

2954

21096

1.01

0.26

4.4

4.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

116

0.81

0.26

1.3

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

503

0.92

0.25

4.4

4.7

77.0

140.2

u/ml

0.39

146

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.20

0.25

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

525

0.92

0.25

1.1

1.2

293.2

188.1

miu/ml

—

(3027315) Oxygen [Partial pressure] in Blood

340

2539

0.97

0.24

3.7

4.4

7.8

8.3

kpa

6.95

327

2461

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

584

0.93

0.24

1.6

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

0.70

0.24

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.24

0.22

1.0

—

35.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

295

1.10

0.22

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.81

0.22

1.6

1.5

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.7

—

8.9

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.22

0.0

7.1

—

6.5

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

558

0.93

0.21

1.8

2.1

17.5

24.6

umol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.8

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

2.3

—

(3001729) Color of Synovial fluid

113

0.83

0.21

1.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.20

0.20

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

152

1148

0.96

0.20

3.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

235

1.11

0.19

1.2

1.3

26.8

29.9

0.20

150

(3029396) Erythrocyte agglutination [Presence] in Blood

1.14

0.19

1.5

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.23

0.18

1.3

1.6

18.9

16.9

umol/l

—

(3013290) Carbon dioxide [Partial pressure] in Blood

341

2526

0.97

0.17

3.7

4.4

5.0

kpa

0.05

329

2448

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

179

0.89

0.17

1.1

—

(3003129) Base excess in Capillary blood by calculation

269

0.91

0.17

1.3

1.9

0.5

0.7

mmol/l

0.11

251

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.74

0.17

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.74

0.17

1.2

1.1

—

(3012501) Base excess in Blood by calculation

341

2524

0.97

0.17

3.6

4.4

2.5

2.8

mmol/l

1.16

239

1736

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

245

1.09

0.16

1.3

1.5

17.6

16.7

pmol/l

0.45

191

(3035320) C reactive protein [Mass/volume] in Body fluid

624

0.95

0.16

3.1

2.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

0.15

1.1

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

128

1.13

0.15

1.4

1.7

1.2

ug/l

0.04

119

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

222

0.91

0.15

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

444

0.94

0.14

1.2

1.3

4.2

3.3

mmol/l

1.04

406

(3017704) Immunofixation for Urine

663

1.05

0.14

1.3

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

0.81

0.14

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

558

1.05

0.13

1.2

1.4

—

2.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.15

0.13

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

594

1.05

0.13

1.8

—

(3010421) pH of Blood

404

2867

1.02

0.12

3.4

4.2

7.4

0.57

329

2450

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.86

0.12

1.0

1.1

1.8

1.7

umol/24h

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4734

34039

1.01

0.11

2.6

3.0

141.1

158.4

ug/l

4.68

4074

30258

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

403

0.95

0.11

1.0

—

(3002619) Bacteria identified in Specimen by Culture

194

1.08

0.11

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

293

1.06

0.10

1.6

1.7

11.5

13.8

nmol/l

1.51

264

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11091

80175

0.99

0.10

9.2

11.7

22.4

23.2

u/l

1.34

10309

76150

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.10

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

143

1061

0.97

0.10

2.7

2.9

—

(3044889) 12 lead EKG panel

7910

57220

1.00

0.10

4.6

4.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.06

0.09

1.2

1.1

156.2

284.1

nmol/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.06

0.08

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

1.08

0.08

1.2

1.1

1564.0

1778.4

miu/ml

0.35

147

(3023511) Choriogonadotropin [Units/volume] in Urine

0.80

0.08

1.0

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.05

0.08

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

281

0.95

0.08

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

662

4736

1.01

0.07

3.7

4.5

1.7

1.5

1.57

625

4457

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3684

26509

1.00

0.07

4.4

5.1

21.7

22.6

2.89

1889

14818

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.03

0.07

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

418

1.04

0.07

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.89

0.07

1.4

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.12

0.07

1.2

10.8

12.2

u/l

0.15

(3019977) pH of Arterial blood

703

0.98

0.06

2.0

2.3

7.4

0.42

271

(3005011) Chlamydia sp Ab [Titer] in Serum

0.88

0.06

1.8

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5970

43025

1.00

0.05

2.8

3.1

51.9

57.4

u/l

3.69

5180

38299

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

686

4921

1.01

0.05

1.7

1.8

3.1

2.2

ug/l

0.62

533

4215

(3025549) Creatine [Moles/time] in 24 hour Urine

0.91

0.05

1.3

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.91

0.05

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

328

0.97

0.04

1.2

1.4

17.4

20.7

0.43

267

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1319

9557

1.00

0.04

2.1

2.5

9.9

10.0

umol/l

0.03

1083

8257

(3007930) Methemoglobin/Hemoglobin.total in Blood

653

4687

1.01

0.04

3.7

4.6

0.9

4.78

617

4403

(44790047)

120

879

0.99

0.04

1.3

—

(44790048)

120

879

0.99

0.04

1.3

—

(44790049)

120

879

0.99

0.04

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

174

0.95

0.04

1.0

1.2

0.8

1.7

mmol/l

0.86

101

(3013166) Neutrophils/100 leukocytes in Synovial fluid

323

1.03

0.03

1.3

1.4

74.0

61.4

2.53

279

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

656

4713

1.00

0.03

1.9

2.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.09

0.03

1.0

1.1

—

(44806118)

120

878

0.99

0.03

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

268

0.97

0.03

1.1

—

(3024263) Appearance of Synovial fluid

522

0.98

0.03

1.4

1.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

231

1.03

0.03

2.6

2.2

—

31.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

604

4376

1.00

0.02

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8398

60596

1.00

0.01

3.7

4.4

16.1

16.0

mm/h

0.20

7386

54754

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

543

3930

1.00

0.01

2.7

3.1

4.2

4.3

pmol/l

0.37

447

3330

(44786800) Granulocytes/100 leukocytes in Body fluid

204

1.03

0.01

1.3

1.4

19.4

23.1

0.24

158

(3029075) Extractable nuclear Ab panel - Serum

171

0.97

0.01

1.2

1.0

—

(4212803)

113

0.96

0.01

1.1

—

(3025941) Bacteria identified in Stool by Culture

570

4108

1.00

0.00

1.3

—

(3024928) Oxygen saturation in Venous blood

290

2088

1.00

0.00

1.6

2.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

938

6766

1.00

0.00

1.7

2.1

400.9

387.2

nmol/l

1.21

796

6069

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

124

0.99

0.00

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

118

0.98

0.00

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.04

0.00

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

159

1147

1.00

0.00

1.3

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

637

1.00

0.00

1.1

1.2

1.1

1.5

nmol/l

5.05

575

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.95

0.00

1.1

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(44806071)

0.95

0.00

1.3

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.7

—

2.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.99

0.00

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.94

0.00

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.6

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

70.2

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.5

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.4

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

5.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.92

0.00

1.2

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.93

0.00

1.2

2729.8

333.5

u/l

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_ALZHEIMER_INCLAVO – Alzheimer disease, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer disease, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer disease, including avohilmo (G6_ALZHEIMER_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints